Processing 00000000.tx.1: The Effect of C-Peptide on Cognitive Dysfunction and Hippocampal Apoptosis in Type 1 Diabetic Rats Anders A.F. 

Phrase: "The Effect of C-Peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on Cognitive Dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "Hippocampal Apoptosis in Type 1 Diabetic Rats Anders A.F."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.2: Sima1,2,3, and Zhen-guo Li1,3 1 Department of Pathology, Wayne State University School of Medicine, Wayne State University, Detroit, Michigan 2 Department of Neurology, Wayne State University School of Medicine, Wayne State University, Detroit, Michigan 3 Morris Hood Jr. 

Phrase: "Sima1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Zhen-guo Li1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450477:LI1 [Body Location or Region]
   827   C1420713:LI1 [Gene or Genome]

Phrase: "3 1 Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587487:Pathology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Wayne State University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Wayne State University,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "Detroit,"

Phrase: "Michigan 2 Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587475:Neurology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Wayne State University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Wayne State University,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "Detroit,"

Phrase: "Michigan 3 Morris Hood Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1708595:Jr [Idea or Concept]
   804   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.3: Comprehensive Diabetes Center, Wayne State University School of Medicine, Wayne State University, Detroit, Michigan  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Primary diabetic encephalopathy is a recently recognized late complication of diabetes resulting in a progressive decline in cognitive faculties. 

Phrase: "Comprehensive Diabetes Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "Wayne State University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Wayne State University,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "Detroit,"

Phrase: "Michigan  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Primary diabetic encephalopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085584:Encephalopathy [Disease or Syndrome]
   827   C1963101:Encephalopathy [Finding]

Phrase: "is"

Phrase: "a recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "recognized"

Phrase: "late complication of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0342257:Diabetes Complication [Pathologic Function]
   770   C0009566:Complication [Pathologic Function]
   770   C2362589:Complication [Idea or Concept]

Phrase: "resulting in a progressive decline"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0332294:Resulting in [Functional Concept]
   760   C0205329:Progressive [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "in cognitive faculties."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015535:Faculties [Professional or Occupational Group]
Processing 00000000.tx.4: In the spontaneously type 1 diabetic BB/Wor rat, we recently demonstrated that cognitive impairment was associated with hippocampal apoptotic neuronal loss. 

Phrase: "In the spontaneously type 1 diabetic BB/Wor rat,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0034699:Rat, BB [Mammal]
   795   C0034693:Rat, NOS [Mammal]
   795   C0034721:Rat [Mammal]

Phrase: "we recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "that cognitive impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "was"

Phrase: "associated with hippocampal apoptotic neuronal loss."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1850496:Neuronal loss [Finding]
   754 E C0598940:neuron loss [Finding]
   754   C1836846:Apoptotic neurons [Finding]
   753   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1516044:Apoptotic [Qualitative Concept]
   753   C1517945:Loss [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
   712 E C1660771:neuron apoptosis [Cell Function]
Processing 00000000.tx.5: Here, we demonstrate that replacement of proinsulin C-peptide in this insulinopenic model significantly prevented spatial learning and memory deficits and hippocampal neuronal loss. 

Phrase: "Here,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that replacement of proinsulin C-peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035139:Replacement [Therapeutic or Preventive Procedure]
   753   C0559956:Replacement [Functional Concept]
   753   C1555302:Replacement [Idea or Concept]

Phrase: "in this insulinopenic model significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "spatial learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582587:spatial learning [Mental Process]
   861   C0013621:learning [Educational Activity]
   861   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory deficits"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0233794:Memory Deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "and"

Phrase: "hippocampal neuronal loss."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1850496:Neuronal loss [Finding]
   865 E C0598940:neuron loss [Finding]
   827   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.6: C-peptide replacement prevented oxidative stress, endoplasmic reticulum, nerve growth factor receptor p75, and poly(ADP-ribose) polymeraserelated apoptotic activities. 

Phrase: "C-peptide replacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "endoplasmic reticulum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "nerve growth factor receptor p75,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0254837:Nerve Growth Factor Receptor p75 [Amino Acid, Peptide, or Protein,Receptor]
           Receptor, Nerve Growth Factor
   771   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]
   717   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "poly(ADP-ribose) polymeraserelated apoptotic activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0441655:Activities [Activity]
   766 E C0205177:Activity [Functional Concept]
   766 E C0439167:% activity [Quantitative Concept]
   766 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.7: It partially ameliorated apoptotic stresses mediated via impaired insulin and IGF activities. 

Phrase: "It partially ameliorated apoptotic stresses"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   779   C0038435:Stress [Finding]
   729 E C0231297:Stressful [Functional Concept]

Phrase: "mediated via impaired insulin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.8: These findings were associated with the prevention of increased expression of Bax and active caspase 3 and the frequency of caspase 3positive neurons. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "were"

Phrase: "associated with the prevention of increased expression of Bax"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0199176:Prevention [Therapeutic or Preventive Procedure]
   742   C0205217:Increased [Quantitative Concept]
   742   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0442805:Increased [Functional Concept]
   742   C0812198:BAX [Gene or Genome]
   742   C1706420:PREVENTION [Research Activity]
   742   C2700409:prevention [Qualitative Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "active caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the frequency of caspase 3positive neurons."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.9: The results show that several partially interrelated apoptotic mechanisms are involved in primary encephalopathy and suggest that impaired insulinomimetic action by C-peptide plays a prominent role in cognitive dysfunction and hippocampal apoptosis in type 1 diabetes. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that several partially interrelated apoptotic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0441712:Mechanisms [Functional Concept]
   771 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "involved in primary encephalopathy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0085584:Encephalopathy [Disease or Syndrome]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1314939:Involved [Functional Concept]
   770   C1963101:Encephalopathy [Finding]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that impaired insulinomimetic action by C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441472:Action [Functional Concept]
   748   C3266814:Action [Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a prominent role in cognitive dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "hippocampal apoptosis in type 1 diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.10: Although these abnormalities were not fully prevented by C-peptide replacement, the findings suggest that this regime will substantially prevent cognitive decline in the type 1 diabetic population. 

Phrase: "Although"

Phrase: "these abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0000768:Abnormalities [Congenital Abnormality]
  1000   C0000769:abnormalities [Functional Concept]
   966 E C1704258:Abnormality [Finding]
   916 E C0205161:Abnormal [Qualitative Concept]
   916 E C2347472:% Abnormal [Quantitative Concept]
   916 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "were"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "prevented by C-peptide replacement,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0035139:Replacement [Therapeutic or Preventive Procedure]
   760   C0559956:Replacement [Functional Concept]
   760   C1555302:Replacement [Idea or Concept]
   726   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this regime"

Phrase: "will"

Phrase: "substantially"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "cognitive decline in the type 1 diabetic population."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.11: Primary diabetic encephalopathy is recognized as a late complication of both type 1 and type 2 diabetes (13). 

Phrase: "Primary diabetic encephalopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085584:Encephalopathy [Disease or Syndrome]
   827   C1963101:Encephalopathy [Finding]

Phrase: "is"

Phrase: "recognized as a late complication of both type 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   781   C3258281:Type of complication [Clinical Attribute]
   764   C0441729:Type 1 [Classification]
   742   C0009566:Complication [Pathologic Function]
   742   C0205087:Late [Temporal Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C1547052:*Type [Quantitative Concept]
   742   C2362589:Complication [Idea or Concept]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.12: Impairments in learning, memory, problem solving, and mental and motor speed are more common in type 1 diabetic patients than in the general population (4,5). 

Phrase: "Impairments in learning,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0684336:Impairments [Pathologic Function]
   790   C2598156:Impairments [Clinical Attribute]

Phrase: "memory,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "problem solving,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033211:Problem Solving [Mental Process]

Phrase: "and"

Phrase: "mental"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0229992:mental [Mental Process]
   916 E C0229993:Psychic [Functional Concept]
   900 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   900 E C0042241:DIAPHRAGM [Medical Device]
   900 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   900 E C1705367:Diaphragm [Medical Device]
   888 E C0086045:mindfulness [Mental Process]
   888 E C3542996:Mindfulness [Mental Process]

Phrase: "and"

Phrase: "motor speed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678536:Speed [Quantitative Concept]

Phrase: "are"

Phrase: "more common in type 1 diabetic patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205214:Common [Quantitative Concept]
   748   C1522138:Common [Functional Concept]
   748   C3245511:common [Intellectual Product]

Phrase: "than"

Phrase: "in the general population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.13: A diabetes durationdependent decline in cognitive function occurs independently of hypoglycemic episodes (6), and impaired intellectual and cognitive developments in type 1 diabetic children correlate with diagnosis at young age, male sex, and metabolic status (7). 

Phrase: "A diabetes durationdependent decline in cognitive function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   774   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]

Phrase: "occurs independently of hypoglycemic episodes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0745153:Hypoglycemic episodes [Disease or Syndrome]
   781   C0332189:Episode of [Temporal Concept]
           Episodes
   760   C0020616:Hypoglycaemic [Pharmacologic Substance]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "impaired intellectual"

Phrase: "and"

Phrase: "cognitive developments in type 1 diabetic children"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C1516691:Cognitive [Functional Concept]
   745   C0679035:Cognitive Development [Mental Process]
   741   C0008071:Child Development [Organism Function]
   714   C0243107:development [Physiologic Function]
   714   C0678723:Development [Organism Function]
   714   C1527148:Development [Functional Concept]

Phrase: "correlate with diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011900:Diagnosis [Finding]
   790   C1704338:diagnosis [Qualitative Concept]
   790   C1704656:DIAGNOSIS [Research Activity]

Phrase: "at young age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "male sex,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0024554:MALE SEX [Finding]
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "metabolic status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.14: Cognitive deficits (8,9) and poor performances in abstract reasoning and complex psychomotor functioning (10,11) occur in type 2 diabetes. 

Phrase: "Cognitive deficits"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0679466:Cognitive deficits [Mental or Behavioral Dysfunction]
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: "and"

Phrase: "poor performances in abstract reasoning"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0597198:performances [Individual Behavior]
   726 E C1882330:Performance [Activity]

Phrase: "and"

Phrase: "complex psychomotor functioning"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C0033923:psychomotor function [Mental Process]
   827   C0542341:functioning [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]

Phrase: "(10,"

Phrase: "11"

Phrase: ")"

Phrase: "occur in type 2 diabetes."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.15: Learning and memory dysfunctions are more prominent in elderly type 2 diabetic patients (9,10). 

Phrase: "Learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory dysfunctions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0233794:Memory dysfunction [Mental or Behavioral Dysfunction]
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   789 E C0231174:Malfunction [Functional Concept]
   789 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "are"

Phrase: "more prominent in elderly type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205402:Prominent [Qualitative Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.16: It has not been determined whether this is because of potentiation of the normal aging process, a function of diabetes duration, or both. 

Phrase: "It"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined"

Phrase: "whether"

Phrase: "this"

Phrase: "is because of potentiation of the normal aging process,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C1510835:Aging Process [Organism Function]
   742   C0001811:Ageing [Organism Function]
   742   C0205307:Normal [Qualitative Concept]
   742   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   742   C0439166:% normal [Quantitative Concept]
   742   C1184743:Process [Body Part, Organ, or Organ Component]
   742   C1522240:Process [Phenomenon or Process]
   742   C2347086:% Normal [Quantitative Concept]

Phrase: "a function of diabetes duration,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.17: Notably, Alzheimers disease is twice as prevalent in the diabetic population as in nondiabetic subjects (12,13). 

Phrase: "Notably,"

Phrase: "Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "twice as prevalent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]
   718   C0033105:Prevalence [Quantitative Concept]
   718   C0220900:prevalence [Quantitative Concept]

Phrase: "in the diabetic population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "as in nondiabetic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.18: Several recent studies have implicated abnormal function of the insulin/IGF axis in the early pathogenesis of Alzheimers disease (14,15). 

Phrase: "Several recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "implicated abnormal function of the insulin/IGF axis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0700205:Function Axis [Classification]
           FUNCTION
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C1705273:Function [Intellectual Product]

Phrase: "in the early pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.19: Insulin and IGF-1 are believed to regulate -amyloid levels (14,16) and tau phosphorylation (16). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "are"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate -"

Phrase: "amyloid levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(14,"

Phrase: "16"

Phrase: ")"

Phrase: "and"

Phrase: "tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.20: Impaired spatial learning and memory occur in animal models of both type 1 and type 2 diabetes (1722). 

Phrase: "Impaired spatial learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0582587:spatial learning [Mental Process]
   827   C0013621:learning [Educational Activity]
   827   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "occur in animal models of both type 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0441729:Type 1 [Classification]
   770   C0599779:Models, Animal [Animal]
   744   C0003062:Animal [Animal]
   744   C0332307:Type [Qualitative Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]
   744   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(1722"

Phrase: ")."
Processing 00000000.tx.21: In the hippocampus of streptozotocin-induced diabetic rats, long-term potentiation is impaired, whereas long-term depression is enhanced (19,23,24), indicating altered hippocampal synaptic plasticity, which is associated with deficits in spatial learning and memory (19,24), which are corrected by insulin treatment (18,25). 

Phrase: "In the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "of streptozotocin-induced diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "long-term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "is"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: ","

Phrase: "whereas"

Phrase: "long-term depression"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C2610415:long term depression [Organ or Tissue Function]
  1000   C2984275:Long-term depression [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0011570:Depression [Mental or Behavioral Dysfunction]
   827   C0011581:Depression [Mental or Behavioral Dysfunction]
   827   C0205166:Long [Qualitative Concept]
   827   C0344315:Depression [Finding]
   827   C0349217:depression nos [Mental or Behavioral Dysfunction]
   827   C0460137:Depression [Functional Concept]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]
   755 E C0549249:DEPRESSED [Finding]

Phrase: "is"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "(19,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "altered hippocampal synaptic plasticity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0678558:Plasticity [Natural Phenomenon or Process]
   741 E C0032167:Plastic [Substance]

Phrase: "which"

Phrase: "is"

Phrase: "associated with deficits"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C2987487:deficits [Qualitative Concept]
   756 E C0162429:Deficit, NOS [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in spatial learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582587:spatial learning [Mental Process]
   861   C0013621:learning [Educational Activity]
   861   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "(19,"

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "corrected by insulin treatment"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205202:Corrected [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C2349182:Correct [Qualitative Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(18,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.22: In the type 1 BB/Wor rat, impaired spatial learning and memory, as assessed by the Morris water maze paradigm (26), occur with duration of diabetes (21). 

Phrase: "In the type 1 BB/Wor rat,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rat, BB [Mammal]
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "spatial learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582587:spatial learning [Mental Process]
   861   C0013621:learning [Educational Activity]
   861   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]

Phrase: "as"

Phrase: "assessed by the Morris water maze paradigm"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0083355:MAZE [Therapeutic or Preventive Procedure]
   748   C0599638:WATER [Substance]
   748   C0681797:paradigm [Research Activity]
   748   C0870866:maze [Manufactured Object]
   748   C1516048:Assessed [Activity]
   748   C1550678:Water [Inorganic Chemical]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "occur with duration of diabetes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0449238:Duration [Temporal Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.23: These changes are associated with impaired insulin and IGF-1 action and neuronal apoptotic stress in the hippocampus and frontal cortex, resulting in significant progressive neuronal losses in the CA1 and CA2 regions of the hippocampus (21). 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "associated with impaired insulin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-1 action"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441472:Action [Functional Concept]
   827   C3266814:Action [Activity]
   734   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "neuronal apoptotic stress in the hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0038435:Stress [Finding]

Phrase: "and"

Phrase: "frontal cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "resulting in significant progressive neuronal losses"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   790   C0332294:Resulting in [Functional Concept]
   773   C1850496:Neuronal loss [Finding]
   753   C0205329:Progressive [Functional Concept]
   753   C0237881:significant [Quantitative Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C0678226:resulting [Functional Concept]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]
   737 E C0598940:neuron loss [Finding]
   719 E C1274040:Result [Functional Concept]
   719   C1517945:Loss [Quantitative Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "in the CA1"

Phrase: "and"

Phrase: "CA2 regions of the hippocampus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.24: The hyperglycemia- and duration-matched type 2 BBZDR rat reveals, by comparison, a milder neuronal loss of the hippocampal CA1 region (22). 

Phrase: "The hyperglycemia-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "duration-matched type 2 BBZDR rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:Rat, NOS [Mammal]
   799   C0034721:Rat [Mammal]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: ","

Phrase: "by comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "a milder neuronal loss of the hippocampal CA1 region"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   764   C1850496:Neuronal loss [Finding]
   760   C0598940:Loss of neurons [Finding]
       E   neuron loss
   742   C1517945:Loss [Quantitative Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.25: In a recent study, various apoptotic activities in these two models were compared. 

Phrase: "In a recent study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "various apoptotic activities in these two models"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.26: Fas/tumor necrosis factor receptor family and low-affinity nerve growth factor receptor (NGFR) p75 activation, indexes of oxidative stress, and endoplasmic reticulum dysfunction were identified in type 1 BB/Wor rats but not in type 2 BBZDR rats, whereas perturbations of the IGF system and poly(ADP-ribose) polymerase (PARP) activation were demonstrated in both models (22). 

Phrase: "Fas/tumor necrosis factor receptor family"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   947   C0077503:Tumor Necrosis Factor Receptor Family [Amino Acid, Peptide, or Protein,Receptor]
           Tumor Necrosis Factor Receptor
   799   C0015576:Family [Family Group]
   799   C1704727:Family [Conceptual Entity]
   727 E C0241888:Familial [Functional Concept]
   709   C0245662:fas Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "low-affinity nerve growth factor receptor (NGFR) p75 activation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   822   C1514758:Receptor Activation [Cell Function]
   793   C1879547:Activation [Activity]
   756   C0254837:Nerve Growth Factor Receptor, Low-Affinity [Amino Acid, Peptide, or Protein,Receptor]
           Nerve Growth Factor Receptor p75
   756   C1334879:low affinity nerve growth factor receptor [Gene or Genome]

Phrase: "indexes of oxidative stress,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C0600653:Indexes [Intellectual Product]
   770   C0918012:Index [Intellectual Product]
   770   C1552854:index [Idea or Concept]
   770   C1637833:% index [Quantitative Concept]

Phrase: "and"

Phrase: "endoplasmic reticulum dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "were"

Phrase: "identified in type 1 BB/Wor rats"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0441729:Type 1 [Classification]
   774   C0034699:Rats, BB [Mammal]
   757   C1514732:Rat-1 [Cell]
   748   C0004739:BB [Geographic Area]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0205396:Identified [Qualitative Concept]
   748   C0332297:BB [Spatial Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "but"

Phrase: "not in type 2 BBZDR rats,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0441730:Type 2 [Classification]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0332307:Type [Qualitative Concept]
   753   C1518422:Not [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "whereas"

Phrase: "perturbations of the IGF system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332453:perturbation [Functional Concept]

Phrase: "and"

Phrase: "poly(ADP-ribose) polymerase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           poly ADP polymerase
  1000   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]
   923   C0032403:Poly ADP Ribose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001461:ADP Ribose [Biologically Active Substance,Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035549:Ribose [Carbohydrate]
   812   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0523452:ADP [Laboratory Procedure]
   812   C0747726:POLY [Conceptual Entity]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: ")"

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "were"

Phrase: "demonstrated in both models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Models [Intellectual Product]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.27: These findings suggest that partially different apoptotic mechanisms are activated, underpinning hippocampal neuronal loss and cognitive dysfunction in the two types of diabetes, and that the combined apoptotic stress is greater in type 1 diabetes. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that partially different apoptotic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: ","

Phrase: "underpinning"

Phrase: "hippocampal neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1850496:Neuronal loss [Finding]
   865 E C0598940:neuron loss [Finding]
   827   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "cognitive dysfunction in the two types of diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   744   C0031847:dysfunction [Functional Concept]
   744   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the combined apoptotic stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "greater in type 1 diabetes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.28: To explore the relative contributions by hyperglycemia and impaired insulinomimetic effects by C-peptide deficiency, we examined the effects of proinsulin C-peptide replacement on cognitive dysfunction and hippocampal apoptosis in type 1 BB/Wor rats. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the relative contributions by hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "impaired insulinomimetic effects by C-peptide deficiency,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of proinsulin C-peptide replacement"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on cognitive dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "hippocampal apoptosis in type 1 BB/Wor rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.29: C-peptide, which is deficient in type 1 diabetes, signals through the insulin signaling pathway (27) but has no effect on hyperglycemia (28). 

Phrase: "C-peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "is"

Phrase: "deficient in type 1 diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011155:Deficient [Functional Concept]
   760   C1636779:% deficient [Quantitative Concept]

Phrase: "signals through the insulin signaling pathway"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   833   C1512804:Insulin Signaling Pathway [Molecular Function]
   833   C2984300:Insulin signaling pathway [Molecular Function]
   790   C0037083:signaling pathway [Cell Function]
           Signaling
   790   C0086982:Signaling Pathway [Molecular Function]
   783   C0037080:Signal Pathway [Molecular Function]
       E   pathway signaling
   783   C2984427:Insulin Pathway [Functional Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C1710082:Signal [Phenomenon or Process]
   753   C3537152:signaling [Biologic Function]

Phrase: "(27"

Phrase: ")"

Phrase: "but"

Phrase: "has"

Phrase: "no effect on hyperglycemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.30: In both human (rev. in 29) and animal (rev. in 30,31) diabetes, it has beneficial metabolic effects on endothelial and inducible nitric oxide synthase and Na+/K+ ATPase activities via mitogen-activated protein kinasedependent transcription (32,33). 

Phrase: "In both human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "(rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "in 29"

Phrase: ")"

Phrase: "and"

Phrase: "animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "(rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "in 30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "it"

Phrase: "has"

Phrase: "beneficial metabolic effects on endothelial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C2945675:metabolic effects [Physiologic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "inducible nitric oxide synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "Na+/K+ ATPase activities via mitogen-activated protein kinasedependent transcription"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   808   C1149024:(Na+ + K+)-activated ATPase activity [Molecular Function]
           (Na+ + K+)-ATPase activity
   743   C1148926:ATPase activity [Molecular Function]
   741   C1537044:protein activity [Molecular Function]
   739   C0441655:Activities [Activity]
   706 E C0205177:Activity [Functional Concept]
   706 E C0439167:% activity [Quantitative Concept]
   706 E C1561536:*Activity [Idea or Concept]
   705   C1752930:mitogenic activity [Cell Function]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.31: In vitro and in vivo studies show gene-regulatory effects on the IGF and nerve growth factor (NGF) systems, and cell adhesive molecules mediated via c-fos, c-jun, and nuclear factor-B (NF-B) (28,34,35). 

Phrase: "In vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0681829:in vivo study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "gene-regulatory effects on the IGF"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "nerve growth factor (NGF) systems,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   845   C0027763:Systems, Nervous [Body System]
   828 E C0422837:NERVOUS SYSTEM [Finding]
   828 E C1269560:Nervous system [Body System]
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   756   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "cell adhesive molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "mediated via c-fos,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "c-jun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "nuclear factor-B (NF-B) (28,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C1824728:FACTOR B [Gene or Genome]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.32: C-peptide facilitates posttranslational modifications of neuronal proteins via phosphorylation or phosphatidylinositol (PI)-3 kinase p85 adducts and inhibits O-linked N-acetylglucosamine glycation (28). 

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "facilitates"

Phrase: "posttranslational modifications of neuronal proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   824   C0033666:Protein Modifications, Post-Translational [Molecular Function]
           Post-Translational Modifications
           Protein Modification
   764   C2263112:protein modification [Molecular Function]
   726   C0392747:Modification [Functional Concept]
   726   C1554963:modification [Qualitative Concept]

Phrase: "via phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "phosphatidylinositol (PI)-3 kinase p85 adducts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0596040:adducts [Chemical Viewed Structurally]
   717   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "O-linked N-acetylglucosamine glycation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0598528:glycation [Phenomenon or Process]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.33: Effects on neuronal apoptosis include corrective effects on the PI-3 kinase pathway and the bidirectional regulation of p38 mitogen-activated protein kinase and jun NH2-terminal kinase and on NF-B via disinhibition by phosphorylated inhibitor of B, as well as PI-3 kinasemediated phosphorylation of Bcl2 (34). 

Phrase: "Effects on neuronal apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "corrective effects on the PI-3 kinase pathway"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "the bidirectional regulation of p38 mitogen-activated protein kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "jun NH2-terminal kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0248813:jun-NH2-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1334482:Jun kinase [Gene or Genome]
   902   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and on NF-B"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   806   C1824728:FACTOR B [Gene or Genome]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1515981:And [Idea or Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "via disinhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234410:Disinhibition [Organ or Tissue Function]
  1000   C0424296:Disinhibition [Mental or Behavioral Dysfunction]

Phrase: "by phosphorylated inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "of B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "as well as"

Phrase: "PI-3 kinasemediated phosphorylation of Bcl2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1753032:phosphatidylinositol phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.34: These effects are analogous to those induced by insulin and are enhanced synergistically by C-peptide at low insulin levels (36,37).  

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "analogous to those"

Phrase: "induced by insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "are"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "synergistically by C-peptide"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   819 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "at low insulin levels"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0861023:low insulin [Finding]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.35: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Pre-diabetic male BB/Wor rats and sex- and age-matched nondiabetes-prone BB rats were obtained from Biomedical Research Models (Worcester, MA). 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Pre-diabetic male BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0034699:Rats, BB [Mammal]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "sex-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "age-matched nondiabetes-prone BB rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0034699:Rats, BB [Mammal]
   799   C0004739:BB [Geographic Area]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]
   799   C0332297:BB [Spatial Concept]

Phrase: "were"

Phrase: "obtained from Biomedical Research Models"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0005540:Biomedical Research [Research Activity]
   797   C0699956:models research [Intellectual Product]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C1301820:Obtained [Functional Concept]
   760   C1879848:Biomedical [Biomedical Occupation or Discipline]
   760   C3161035:Models [Intellectual Product]
   726 E C1706701:Obtain [Activity]

Phrase: "(Worcester,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.36: BB/Wor rats developed diabetes spontaneously at 71  3 days of age. 

Phrase: "BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "developed"

Phrase: "diabetes spontaneously at 71  3 days of age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.37: They were given small daily substitution doses (0.53.0 IU) of protamine zinc insulin (Blue Ridge Pharmaceuticals, Greensboro, NC) to maintain glucose levels at 20.025.0 mmol/l and to prevent ketoacidosis (38). 

Phrase: "They"

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "small daily substitution doses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   858   C2348070:Daily Dose [Quantitative Concept]
   812   C0178602:Doses [Quantitative Concept]
   779 E C0869039:Dose [Quantitative Concept]
   779 E C1114758:Dose # [Clinical Attribute]
   779 E C1428722:DOS [Gene or Genome]

Phrase: "(0.53.0 IU) of protamine zinc insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439453:IU [Quantitative Concept]

Phrase: "(Blue Ridge Pharmaceuticals,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1135440:Pharmaceuticals [Therapeutic or Preventive Procedure]
   827   C1254351:Pharmaceuticals [Pharmacologic Substance]
   793 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]

Phrase: "Greensboro,"

Phrase: "NC) to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027964:NC [Geographic Area]
   861   C0028407:NC [Geographic Area]
   861   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "glucose levels at 20.025.0 mmol/l"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0428548:glucose levels [Laboratory or Test Result]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0441889:Levels [Qualitative Concept]
   737 E C0337438:glucose level [Laboratory Procedure]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "ketoacidosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022638:Ketoacidosis [Disease or Syndrome]
  1000   C0220982:KETO ACIDOSIS [Pathologic Function]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.38: Diabetic animals were kept in metabolic cages and monitored daily for body weight, urine volume, glucose, and ketones based on which daily insulin doses were titrated. 

Phrase: "Diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "kept in metabolic cages"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0311400:Metabolic [Functional Concept]
   770   C0337189:cages [Manufactured Object]
   770   C1524026:Metabolic [Cell Function]
   770   C2707259:Metabolic [Clinical Attribute]
   737   C0333118:Keep [Functional Concept]
   737 E C0441239:Cage [Medical Device]

Phrase: "and"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "daily for body weight,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0005910:Body Weight [Organism Attribute]
           weight
   833   C1305866:body weight [Diagnostic Procedure]
           weight
   770   C0043100:Weight [Quantitative Concept]
   770   C0242821:body [Human]
   770   C0332173:Daily [Temporal Concept]
   770   C0460148:Body [Anatomical Structure]
   770   C1268086:Body [Anatomical Structure]
   770   C1705104:Weight [Idea or Concept]

Phrase: "urine volume,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0232856:Urine volume [Clinical Attribute]
  1000   C1278293:Urine volume [Laboratory Procedure]
  1000   C1287298:Urine volume [Finding]
   861   C0042036:Urine [Body Substance]
   861   C0042037:urine [Functional Concept]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
   861   C2963137:Urine [Body Substance]

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "ketones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022634:Ketones [Organic Chemical]

Phrase: "based on which daily insulin doses"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   767   C2348070:Daily Dose [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0178602:Doses [Quantitative Concept]
   753   C0332173:Daily [Temporal Concept]
   753   C1527178:Based [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C0869039:Dose [Quantitative Concept]
   719 E C1114758:Dose # [Clinical Attribute]
   719 E C1428722:DOS [Gene or Genome]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "were"

Phrase: "titrated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883350:Titrate [Health Care Activity]
Processing 00000000.tx.39: Blood glucose levels were examined biweekly using glucose test strips (Bayer, Elkhart, IN). 

Phrase: "Blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "biweekly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0585332:Biweekly [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "glucose test strips"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   913   C0182876:glucose strips [Indicator, Reagent, or Diagnostic Aid]
   901   C2700619:test strips [Medical Device]
   867 E C1553116:Test strip [Laboratory Procedure]
   867 E C1705054:Test Strip [Medical Device]
   827   C1321564:strips [Medical Device]
   734   C0337438:glucose test [Laboratory Procedure]
   734   C0595310:GLUCOSE TEST [Medical Device]

Phrase: "(Bayer,"

Phrase: "Elkhart,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.40: The animals had free access to rat diet and drinking water. 

Phrase: "The animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "free access to rat diet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444454:Access [Spatial Concept]
   760   C1554204:access [Idea or Concept]

Phrase: "and"

Phrase: "drinking water."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0599638:Drinking Water [Substance]
           WATER
   861   C0001948:drinking [Individual Behavior]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0684271:Drinking [Organism Function]
   861   C1550678:Water [Inorganic Chemical]
   827 E C0452428:Drink [Food]
   789 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.41: In 10 diabetic BB/Wor rats, rat II C-peptide replacement doses (75 mmol  kg1  day1; Sigma Genosys, The Woodlands, TX) were delivered from onset of diabetes via subcutaneously implanted osmopumps (Alzet, Palo Alto, CA) (28,39). 

Phrase: "In 10 diabetic BB/Wor rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "rat II C-peptide replacement doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0178602:Doses [Quantitative Concept]
   766 E C0869039:Dose [Quantitative Concept]
   766 E C1114758:Dose # [Clinical Attribute]
   766 E C1428722:DOS [Gene or Genome]

Phrase: "(75 mmol  kg1  day1"

Phrase: "; Sigma Genosys,"

Phrase: "The Woodlands,"

Phrase: "TX)"

Phrase: "were"

Phrase: "delivered from onset of diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332162:Onset [Qualitative Concept]
   760   C1705822:Delivered [Activity]
   726 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   726 E C1874964:DELIVER [Pharmacologic Substance]

Phrase: "via subcutaneously implanted osmopumps"

Phrase: "(Alzet,"

Phrase: "Palo Alto,"

Phrase: "CA) (28,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.42: At the time of death (after 8 months of diabetes), blood samples were collected for measurements of blood glucose concentrations and HbA1c levels, which were measured using a DCA 2000 Analyzer (Bayer). 

Phrase: "At the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "("

Phrase: "after 8 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected for measurements of blood glucose concentrations"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   804   C0392201:blood glucose measurements [Laboratory Procedure]
   797   C2585282:Blood glucose concentration [Finding]
   778   C0005802:Blood Glucose [Carbohydrate]
   774   C0337438:glucose measurements [Laboratory Procedure]
   774   C0427728:blood concentrations [Laboratory or Test Result]
   774   C0427743:concentrations glucose [Laboratory Procedure]
   774   C0699870:blood concentrations [Quantitative Concept]
   774   C1287281:concentrations glucose [Laboratory or Test Result]
   774   C1313904:blood concentrations [Laboratory Procedure]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0086045:Concentrations [Mental Process]
   748   C0229664:Blood [Body Substance]
   748   C0242485:measurements [Functional Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   741   C1446561:Concentration measurement [Quantitative Concept]
       E   Concentration
   724   C0429854:Vascular measurements [Laboratory or Test Result]

Phrase: "and"

Phrase: "HbA1c levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a DCA 2000 Analyzer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0179038:Analyzer [Medical Device]
   827   C1706246:Analyzer [Manufactured Object]

Phrase: "(Bayer"

Phrase: ")."
Processing 00000000.tx.43: Plasma levels of insulin, IGF-1, and C-peptide were measured using radioimmunoassays (Linco Research, St. Charles, MO). 

Phrase: "Plasma levels of insulin,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   856   C1276042:Plasma insulin level [Laboratory Procedure]
   819   C0202098:insulin levels [Laboratory Procedure]
   819   C0428405:insulin levels [Laboratory or Test Result]
   819   C0857690:plasma insulin [Laboratory Procedure]
   770   C0032105:Plasma [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "IGF-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "radioimmunoassays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034580:Radioimmunoassays [Laboratory Procedure]

Phrase: "(Linco Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "St. Charles,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.44: The animals were cared for in accordance with institutional and National Institutes of Health guidelines (publication no. 85-23, 1995). 

Phrase: "The animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "cared for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1947933:Care [Activity]

Phrase: "in accordance with institutional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0018704:Institution [Health Care Related Organization,Manufactured Object]
   928   C1272753:Institution [Idea or Concept]
   928   C2607850:Institution [Health Care Related Organization]

Phrase: "and"

Phrase: "National Institutes of Health guidelines"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0162791:Guidelines [Intellectual Product]
   804   C0220845:guidelines [Intellectual Product]
   804   C0282423:guidelines [Intellectual Product]
   771   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health

Phrase: "(publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "no. 85-23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.45: Tissue collection. 

Phrase: "Tissue collection."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040278:Tissue Collection [Health Care Related Organization,Manufactured Object]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   789 E C1516695:Collected [Idea or Concept]
Processing 00000000.tx.46: Animals were anesthetized with isoflurane and decapitated. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "anesthetized with isoflurane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022180:Isoflurane [Organic Chemical,Pharmacologic Substance]
   790   C1720436:Anesthetized [Finding]

Phrase: "and"

Phrase: "decapitated."
Processing 00000000.tx.47: The whole brain was removed and placed on an ice-cooled cutting board. 

Phrase: "The whole brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "placed on an ice-cooled cutting board."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   748   C0020746:Ice [Inorganic Chemical]
   748   C0152060:Cutting, NOS [Therapeutic or Preventive Procedure]
   748   C0972401:board [Medical Device]
   748   C1306235:Cutting [Qualitative Concept]
   748   C1948070:Board [Organization]
   748   C3496294:Cutting [Functional Concept]
   714 E C0000925:Cut [Injury or Poisoning]
   714   C0442504:Place [Spatial Concept]
   714   C1548792:Cool [Qualitative Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714 E C1883724:CUT [Phenomenon or Process]
   714   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.48: After the meninges were removed, the hemispheres from six animals per group were bisected and hippocampi were dissected, snap-frozen in liquid nitrogen, and stored at 70C for purification of protein and DNA. 

Phrase: "After the meninges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025285:Meninges [Body Part, Organ, or Organ Component]
  1000   C2332324:Meninges [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "the hemispheres from six animals"

Phrase: "per group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "bisected"

Phrase: "and"

Phrase: "hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: ","

Phrase: "snap-"

Phrase: "frozen in liquid nitrogen,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]

Phrase: "and"

Phrase: "stored at 70C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "for purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.49: For morphometric analyses, terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) staining and immunocytochemical examinations, hippocampi from four animals per group were fixed in 4% paraformaldehyde (PBS buffered, pH 7.4), paraffin embedded, and 6-m thick sections were prepared as previously described (21). 

Phrase: "For morphometric analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0200760:Morphometric analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   920   C0872284:terminal deoxynucleotidyl transferase nick end labeling [Molecular Biology Research Technique]
   906   C0600528:terminal nick end labeling [Molecular Biology Research Technique]
   793   C1167624:Labeling [Mental Process]
   793   C1947902:Labeling [Manufactured Object]
   793   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(TUNEL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600528:TUNEL [Molecular Biology Research Technique]

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "immunocytochemical examinations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031809:examinations [Health Care Activity]

Phrase: "hippocampi from four animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "per group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "fixed in 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "(PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "buffered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ","

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "paraffin embedded,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   861   C1707903:Embedded [Laboratory Procedure]

Phrase: "and"

Phrase: "6-m thick sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "prepared as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.50: Morris water maze testing. 

Phrase: "Morris water maze testing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0920675:water testing [Occupational Activity]
   812   C0039593:Testing [Functional Concept]
   812   C0392366:testing [Intellectual Product]
Processing 00000000.tx.51: Water maze testing was performed according to Morris (26) before killing the rats. 

Phrase: "Water maze testing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0920675:water testing [Occupational Activity]
   827   C0039593:Testing [Functional Concept]
   827   C0392366:testing [Intellectual Product]

Phrase: "was"

Phrase: "performed according to Morris"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0680240:according [Social Behavior]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(26"

Phrase: ")"

Phrase: "before"

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "the rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.52: Rats were placed in a circular pool of water (2.04 m in diameter x 0.40 m in height), in which a platform was hidden 3 cm beneath the water surface, 40 cm away from the edge of the pool. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "placed in a circular pool of water"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0337051:Pool [Geographic Area]
   748   C0599638:WATER [Substance]
   748   C1282913:Circular [Spatial Concept]
   748   C1509144:pool [Clinical Attribute]
   748   C1550678:Water [Inorganic Chemical]
   748   C2349200:Pool [Functional Concept]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "(2.04 m in diameter x 0.40 m"

Phrase: "in height"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0489786:Height [Organism Attribute]
   928 E C0205250:High [Qualitative Concept]
   928 E C1299351:High [Qualitative Concept]
   928 E C1522410:Highest [Qualitative Concept]
   928 E C2700149:HIGH [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "a platform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710360:Platform [Research Device]

Phrase: "was"

Phrase: "hidden 3 cm beneath the water surface,"

Phrase: "40 cm away from the edge of the pool."
Processing 00000000.tx.53: The water temperature was kept at 28C. 

Phrase: "The water temperature"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "was"

Phrase: "kept at 28C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0333118:Keep [Functional Concept]
Processing 00000000.tx.54: The pool area was arbitrarily divided into four quadrants (Q1Q4). 

Phrase: "The pool area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "was"

Phrase: "arbitrarily"

Phrase: "divided into four quadrants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0439738:Four quadrants [Spatial Concept]
   770   C0205450:Four [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]
   737   C1631280:Quadrant [Spatial Concept]

Phrase: "(Q1Q4"

Phrase: ")."
Processing 00000000.tx.55: On 2 consecutive days each week for 2 weeks, rats were given three acquisition trials per day. 

Phrase: "On 2 consecutive days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1442455:2 Days [Temporal Concept]
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "each week for 2 weeks,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332174:Each week [Temporal Concept]
           /week
   760   C0439230:week [Temporal Concept]

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "three acquisition trials per day."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0008976:Trial [Research Activity]
Processing 00000000.tx.56: The rats were placed at the periphery of the pool facing the wall of Q1Q4. 

Phrase: "The rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "placed at the periphery of the pool"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0337051:Pool [Geographic Area]
   748   C1509144:pool [Clinical Attribute]
   748   C2349200:Pool [Functional Concept]
   714   C0442504:Place [Spatial Concept]
   714   C1704765:Place [Functional Concept]
   714   C1882509:Place [Activity]
   714   C3496241:place [Disease or Syndrome]

Phrase: "facing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015450:Face [Body Location or Region]
   966   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "the wall of Q1Q4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0677535:Wall [Manufactured Object]
Processing 00000000.tx.57: The distances to the platform were 148, 124, 84, and 52 cm for Q1Q4, respectively. 

Phrase: "The distances to the platform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012751:distances [Quantitative Concept]

Phrase: "were"

Phrase: "148,"

Phrase: "124,"

Phrase: "84,"

Phrase: "and"

Phrase: "52 cm for Q1Q4,"

Phrase: "respectively."
Processing 00000000.tx.58: Rats were trained to locate the platform and allowed to stay on it for 30 s before being removed for the next trial. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "trained"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   966   C0336809:Train [Manufactured Object]
   966   C1552514:Train [Manufactured Object]
   928 E C0009647:Conditioned [Mental Process]
   928 E C0012634:condition [Disease or Syndrome]
   928 E C0348080:Condition [Qualitative Concept]
   928 E C1705253:Condition [Conceptual Entity]
   907 E C0040607:Training [Educational Activity]
   907 E C0220931:Training [Educational Activity]
   907 E C2673163:training [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "locate"

Phrase: "the platform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710360:Platform [Research Device]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stay on it"

Phrase: "for 30 s"

Phrase: "before"

Phrase: "being"

Phrase: "removed for the next trial."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0008976:Trial [Research Activity]
   760   C0205117:next [Spatial Concept]
   760   C0332282:Next [Temporal Concept]
   760   C0849355:Removed [Qualitative Concept]
   760   C1883708:Next [Temporal Concept]
   726 E C1883720:Remove [Activity]
   726 E C3244314:remove [Functional Concept]
Processing 00000000.tx.59: Three days after the final day of training, rats were tested and the time was measured in seconds for reaching the platform from the four starting points. 

Phrase: "Three days after the final day of training,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0439228:days [Temporal Concept]
   711 E C0332173:/day [Temporal Concept]
   711 E C0439505:/day [Temporal Concept]

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "measured in seconds"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C0457385:seconds [Temporal Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0205436:Second [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]
   756 E C0565930:/second [Quantitative Concept]
   756 E C1561503:second [Idea or Concept]
   756 E C1705190:Second [Qualitative Concept]
   706 E C0027627:secondary [Neoplastic Process]
   706 E C0175668:Secondary [Temporal Concept]

Phrase: "for reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "the platform from the four starting points."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710360:Platform [Research Device]
Processing 00000000.tx.60: Any rat that failed to find the platform within 100 s was taken out of the water and scored as 100. 

Phrase: "Any rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "that"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "the platform within 100 s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710360:Platform [Research Device]

Phrase: "was"

Phrase: "taken out of the water"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   760   C0439787:Out [Spatial Concept]
   760   C0599638:WATER [Substance]
   760   C0849355:Out [Qualitative Concept]
   760   C1550678:Water [Inorganic Chemical]
   760   C1883727:Taken [Conceptual Entity]
   726 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "scored as 100."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449820:scored [Quantitative Concept]
Processing 00000000.tx.61: Measurement of neuronal density in hippocampus. 

Phrase: "Measurement of neuronal density"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "in hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.62: Hemotoxylin-eosinstained serial paraffin sections were prepared from four hippocampi from individual animals in each group. 

Phrase: "Hemotoxylin-eosinstained serial paraffin sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "prepared from four hippocampi"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0205450:Four [Quantitative Concept]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   737   C1521827:Prepare [Functional Concept]

Phrase: "from individual animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "in each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.63: Regions of hippocampus (CA1CA4) were identified according to Paxinos and Watson (40). 

Phrase: "Regions of hippocampus"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "(CA1CA4"

Phrase: ")"

Phrase: "were"

Phrase: "identified according to Paxinos"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205396:Identified [Qualitative Concept]
   770   C0680240:according [Social Behavior]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "Watson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.64: Images of 15, 6-m thick sections 12 m apart were analyzed using a morphometric analysis system interfaced with Image-Pro Plus 3.0 image analysis software (Media Cybermetics, Silver Spring, MD). 

Phrase: "Images of 15,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1704254:Image [Intellectual Product]
   756   C1704922:Image [Entity]
   756   C3542466:Image [Intellectual Product]

Phrase: "6-m thick sections 12 m apart"

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a morphometric analysis system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0039152:analysis system [Occupational Activity]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C0200760:Morphometric analysis [Laboratory Procedure]

Phrase: "interfaced with Image-Pro Plus 3.0 image analysis software"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   757   C0200765:Image analysis [Laboratory Procedure]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0037585:Software [Intellectual Product,Manufactured Object]
   739   C0332287:Plus [Qualitative Concept]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1704254:Image [Intellectual Product]
   739   C1704922:Image [Entity]
   739   C2987124:PRO [Intellectual Product]
   739   C3542466:Image [Intellectual Product]
   706   C1708533:Interface [Manufactured Object]
   706   C2698172:Interface [Intellectual Product]

Phrase: "(Media Cybermetics,"

Phrase: "Silver Spring,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0037125:Silver [Element, Ion, or Isotope]
   861   C0241232:Spring [Temporal Concept]
   861   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   861   C1305285:Silver [Qualitative Concept]
   861   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   861   C1705204:Spring [Manufactured Object]
   777 E C0079853:Moon [Geographic Area]
   768 E C0003782:Argyria [Injury or Poisoning]
   768 E C3463959:Argyria [Eukaryote]

Phrase: "MD)."
Processing 00000000.tx.65: Only neurons with identifiable nuclei were counted, and neuronal density was expressed as the number of neurons per millimeter squared. 

Phrase: "Only neurons with identifiable nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027882:Neurons [Cell]
   756   C3146324:neuronal nuclei [Gene or Genome]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "neuronal density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "expressed as the number of neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0027882:Neurons [Cell]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "per millimeter squared."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0456786:Millimeter Squared [Quantitative Concept]
   861   C0439200:millimeter [Quantitative Concept]
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]
Processing 00000000.tx.66: Ligation-mediated PCR assay. 

Phrase: "Ligation-mediated PCR assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0243073:assay [Qualitative Concept]
   812   C0677874:pCR [Finding]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.67: Nucleosomal DNA ladder was detected by the ligation-mediated PCR assay method following the manufacturers instruction (Clontech, Palo Alto, CA). 

Phrase: "Nucleosomal DNA ladder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0336762:Ladder [Manufactured Object]

Phrase: "was"

Phrase: "detected by the ligation-mediated PCR assay method"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0023690:Ligation [Therapeutic or Preventive Procedure]
   744   C0025663:Method [Intellectual Product]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0243073:assay [Qualitative Concept]
   744   C0442726:Detected [Finding]
   744   C0449851:Method [Functional Concept]
   744   C0677874:pCR [Finding]
   744   C0871511:METHOD [Intellectual Product]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturers instruction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039401:Instruction [Educational Activity]
   861   C0302828:Instruction [Intellectual Product]
   861   C1442085:instruction [Idea or Concept]

Phrase: "(Clontech,"

Phrase: "Palo Alto,"

Phrase: "CA)."
Processing 00000000.tx.68: For each assay, 0.5 g genomic DNA from four hippocampi per group was extracted (21) and ligated to DNA adapters. 

Phrase: "For each assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "0.5 g genomic DNA from four hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017428:Genomic [Gene or Genome]
   744   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "per group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "(21"

Phrase: ")"

Phrase: "and"

Phrase: "ligated to DNA adapters."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0178959:adapters [Medical Device]
   737 E C1706710:Adapter [Manufactured Object]
   737 E C2346841:Adapter [Intellectual Product]
Processing 00000000.tx.69: The ligated DNA was used as templates for PCR amplification with the adapters as primers. 

Phrase: "The ligated DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as templates"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0728990:templates [Medical Device]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1514575:Template [Conceptual Entity]
   756 E C1705542:Template [Idea or Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "for PCR amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "with the adapters"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0178959:adapters [Medical Device]
   966 E C1706710:Adapter [Manufactured Object]
   966 E C2346841:Adapter [Intellectual Product]

Phrase: "as primers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.70: The resultant nucleosomal ladders were visualized by 1.4% agarose gel electrophoresis. 

Phrase: "The resultant nucleosomal ladders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0336762:ladders [Manufactured Object]

Phrase: "were"

Phrase: "visualized by 1.4% agarose gel electrophoresis."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   814   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   778   C0596607:Gel Electrophoresis [Laboratory Procedure]
   778   C1706746:Agarose Gel [Research Device]
   774 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   748   C0013855:Electrophoresis [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C0234621:Visualized [Functional Concept]
   748   C1382104:Gel [Substance]
Processing 00000000.tx.71: A primer set for human GAPDH cDNA (Clontech) was used for amplification of internal control: 5'-ACCACAGTCCATGCCATCAC and 5'-TCCACCACCCTGTTGCTGTA, which yielded a band of 452 bp. 

Phrase: "A primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "set for human GAPDH cDNA (Clontech"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0036849:Set [Mental Process]
   753   C0086418:Human [Human]
   753   C1414968:GAPDH [Gene or Genome]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]

Phrase: ")"

Phrase: "was"

Phrase: "used for amplification of internal control"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   790   C0597937:internal control [Mental Process]
   767   C1524063:Use of [Functional Concept]
   753   C0205102:Internal [Spatial Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1273517:used [Finding]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1550141:Control [Substance]
   753   C1553872:Internal [Intellectual Product]
   753   C1619620:Internal [Intellectual Product]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "5'-ACCACAGTCCATGCCATCAC"

Phrase: "and"

Phrase: "5'-TCCACCACCCTGTTGCTGTA,"

Phrase: "which"

Phrase: "yielded"

Phrase: "a band of 452 bp."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0230715:A band [Cell Component]
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]
Processing 00000000.tx.72: TUNEL staining. 

Phrase: "TUNEL staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.73: TUNEL staining was performed as previously described (21). 

Phrase: "TUNEL staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.74: A Neuro TACS II apoptosis labeling kit (Trevigen, Gaithersburg, MD) was used for labeling apoptotic nuclei on 6-m thick paraffin sections. 

Phrase: "A Neuro TACS II apoptosis labeling kit (Trevigen,"

Phrase: "Gaithersburg,"

Phrase: "MD)"

Phrase: "was"

Phrase: "used for labeling apoptotic nuclei"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C2751835:Apoptotic nuclei [Finding]
   760   C1167624:Labeling [Mental Process]
   760   C1273517:used [Finding]
   760   C1516044:Apoptotic [Qualitative Concept]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]
   726   C0007610:Nucleus [Cell Component]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "on 6-m thick paraffin sections."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]
Processing 00000000.tx.75: Endogenous hydrogenase was quenched by 3% hydrogen peroxide. 

Phrase: "Endogenous hydrogenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020284:Hydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "quenched by 3% hydrogen peroxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0020275:Hydrogen [Element, Ion, or Isotope]
   760   C0031180:Peroxide [Inorganic Chemical]
   760   C0523702:HYDROGEN [Laboratory Procedure]
   760   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.76: Biotinylated nucleotides were incorporated into the DNA breaks with TdT in the presence of dNTP mix and Mn++. 

Phrase: "Biotinylated nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "incorporated into the DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "breaks with TdT"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0012881:Terminal Deoxynucleotidyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Deoxynucleotidyl Transferase
           Terminal Transferase
   862   C0687124:Terminal deoxynucleotidyl transferase [Indicator, Reagent, or Diagnostic Aid]
   862   C1333243:DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL [Gene or Genome]
           TERMINAL TRANSFERASE
   760   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205088:Terminal [Temporal Concept]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   760   C1881704:BREAK [Phenomenon or Process]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of dNTP mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205430:Mix [Functional Concept]
   861   C1421951:MIX [Gene or Genome]
   861   C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "Mn++."
Processing 00000000.tx.77: Incorporated biotinylated nucleotides were incubated with (strep)-avidin horseradish peroxidase, and 3,3'-diaminobenzidine tetrahydrochloride was used as chromogen. 

Phrase: "Incorporated"

Phrase: "biotinylated nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "(strep)-avidin horseradish peroxidase,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   812   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0330510:Horseradish [Food]
   812   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   812   C1110641:Horseradish [Plant]
   812   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3'-diaminobenzidine tetrahydrochloride"

Phrase: "was"

Phrase: "used as chromogen."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0052799:Chromogen [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.78: Positive controls were generated by using DNase-1 to "nick" the DNA, and for negative controls, TdT was omitted. 

Phrase: "Positive controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1883676:Positive Control [Conceptual Entity]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "generated by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DNase-1 to """
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "nick"

Phrase: """"

Phrase: "the DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and for negative controls,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   799   C1639518:% negative control [Quantitative Concept]
   799   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C1515981:And [Idea or Concept]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "TdT"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0012881:Terminal Deoxynucleotidyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Terminal Transferase
           Deoxynucleotidyl Transferase
  1000   C0687124:Terminal deoxynucleotidyl transferase [Indicator, Reagent, or Diagnostic Aid]
  1000   C1333243:DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL [Gene or Genome]
           TERMINAL TRANSFERASE
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "was"

Phrase: "omitted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]
Processing 00000000.tx.79: The frequencies of TUNEL-positive nuclei were calculated in each of the four hippocampal sectors (CA1CA4). 

Phrase: "The frequencies of TUNEL-positive nuclei"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "were"

Phrase: "calculated in each of the four hippocampal sectors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   744   C0205450:Four [Quantitative Concept]
   744   C0444686:Calculated [Functional Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   711   C1708237:Sector [Geographic Area]

Phrase: "(CA1CA4"

Phrase: ")."
Processing 00000000.tx.80: Immunoblotting. 

Phrase: "Immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.81: Dissected hippocampi from four animals per group were used. 

Phrase: "Dissected hippocampi from four animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "per group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.82: Protein lysates (40 g per lane) were resolved by SDS-PAGE under reducing conditions and transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA). 

Phrase: "Protein lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "(40 g per lane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1955160:40 g [Quantitative Concept]
   770   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "under reducing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "transferred onto polyvinylidene difluoride membranes"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C0596901:Membrane [Cell Component]
   726 E C1705822:Transfer [Activity]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "(Millipore,"

Phrase: "Bedford,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.83: The membranes were stained with 1% Ponseau S to control for equal loading of protein. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "stained with 1% Ponseau S to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "control for equal loading of protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205163:Equal [Qualitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1549782:Equal [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1708715:Loading [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.84: The blots were incubated with blocking buffer, 0.1% Tween 20 and 5% nonfat milk (Bio-Rad, Hercules, CA), in Tris-buffered saline (TBS) (pH 7.4) and incubated with the same blocking buffer containing the primary antibody. 

Phrase: "The blots"

Phrase: "were"

Phrase: "incubated with blocking buffer,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "0.1% Tween 20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5% nonfat milk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0026131:Milk [Body Substance]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "(Bio-Rad,"

Phrase: "Hercules,"

Phrase: "CA),"

Phrase: "in Tris-buffered saline (TBS)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "incubated with the same blocking buffer"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0233660:Blocking [Mental or Behavioral Dysfunction]
   753   C0332206:Blocking [Functional Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C0028778:Block [Pathologic Function]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the primary antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.85: The primary antibodies were mouse anti-Bax and antiBcl-xL antibodies (Trevigen); 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "mouse anti-Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "antiBcl-xL antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Trevigen"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.86: rabbit antiactive caspase 3, anticaspase 12, and antiNGFR p75 antibodies (Chemicon, Temecula, CA); 

Phrase: "rabbit antiactive caspase 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "anticaspase 12,"

Phrase: "and"

Phrase: "antiNGFR p75 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Chemicon,"

Phrase: "Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA)"

Phrase: ";"
Processing 00000000.tx.87: rabbit anti89 kDa-PARP antibody (Roche Diagnostics, Mannheim, Germany); 

Phrase: "rabbit anti89 kDa-PARP antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Roche Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.88: mouse anti-Fas antibody (BD Biosciences, Lexington, KY); 

Phrase: "mouse anti-Fas antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(BD Biosciences,"

Phrase: "Lexington,"

Phrase: "KY"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.89: goat antiIGF-1 and antiIGF-2 antibodies; 

Phrase: "goat antiIGF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0018019:goat [Mammal]
   827   C1265549:goat [Mammal]
   827   C1510458:Goat [Mammal]

Phrase: "and"

Phrase: "antiIGF-2 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.90: and rabbit antiIGF-I receptor (IGF insulin receptor), antiinsulin receptor -subunit, antiNGF high-affinity receptor (NGFR-TrKA), and anti-NGF antibodies (Santa Cruz Biotechnology, Santa Cruz, CA). 

Phrase: "and"

Phrase: "rabbit antiIGF-I receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(IGF insulin receptor"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C0140079:IGF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "antiinsulin receptor -subunit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "antiNGF high-affinity receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(NGFR-TrKA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   804   C0072482:Trk-A [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   804   C0919487:TRKA [Gene or Genome]
   804   C1704884:TRKA [Gene or Genome]
   771   C0254837:Receptor, Nerve Growth Factor [Amino Acid, Peptide, or Protein,Receptor]
   771   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]
   717   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti-NGF antibodies"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   897   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   881 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0443887:Nerve antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0814002:Neural Growth [Cell Function,Organism Function]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0027740:Nerve [Tissue]
   804   C0027757:NERVE [Tissue]
   804   C0220844:growth [Physiologic Function]
   804   C1280541:Nerve [Body Part, Organ, or Organ Component]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748 E C0599851:Neural [Functional Concept]
   733 E C0027769:nervy [Sign or Symptom]

Phrase: "(Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.91: After four washings, blots were incubated with the appropriate horseradish peroxidaseconjugated secondary antibody (Sigma Chemical, St. Louis, MO) and exposed to an enhanced chemiluminescence detection system (Amersham Pharmacia Biotech, Piscataway, NJ). 

Phrase: "After four washings,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Washing [Activity]

Phrase: "blots"

Phrase: "were"

Phrase: "incubated with the appropriate horseradish peroxidaseconjugated secondary antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0027627:secondary [Neoplastic Process]
   744   C0175668:Secondary [Temporal Concept]
   744   C0205436:Secondary [Quantitative Concept]
   744   C0330510:Horseradish [Food]
   744   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   744   C1110641:Horseradish [Plant]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1548787:Appropriate [Qualitative Concept]

Phrase: "(Sigma Chemical, St. Louis,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "and"

Phrase: "exposed to an enhanced chemiluminescence detection system"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   748   C0449913:System [Functional Concept]
   748   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C2349975:Enhanced [Activity]

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.92: Immunocytochemistry. 

Phrase: "Immunocytochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]
Processing 00000000.tx.93: Hippocampi from four animals per group were examined. 

Phrase: "Hippocampi from four animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "per group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.94: Deparaffinized 6-m sections were incubated with the primary antibody for 30 min at room temperature, washed with three changes of TBS, and incubated with the peroxidase-conjugated secondary antibody for 30 min at room temperature. 

Phrase: "Deparaffinized"

Phrase: "6-m sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with the primary antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "washed with three changes of TBS,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   754   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0036082:Saline [Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0205449:Three [Quantitative Concept]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   744   C0814229:TRI [Intellectual Product]
   744   C1548982:Washed [Idea or Concept]
   711 E C0441648:Wash [Activity]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "incubated with the peroxidase-conjugated secondary antibody"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0027627:secondary [Neoplastic Process]
   748   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0522529:Conjugated [Spatial Concept]
   748   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.95: The immunoreactive products were visualized with 3,3'-diaminobenzidine tetrahydrochloride as chromogen. 

Phrase: "The immunoreactive products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "visualized with 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]

Phrase: "3'-diaminobenzidine tetrahydrochloride as chromogen."
Processing 00000000.tx.96: The primary antibodies used were rabbit anti-caspase 12 and antiapoptosis-inducing factor (AIF) antibodies (Chemicon), mouse anti8-hydroxyl-2'-deoxyguanosine (8-OHdG) antibody (Genox, Baltimore, MD), rabbit anti-PARP (Roche Diagnostic), and mouse anti-Fas antibody (BD Biosciences) sections were counterstained. 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "rabbit anti-caspase 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0911469:Caspase 12 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0034493:Rabbit [Mammal]

Phrase: "and"

Phrase: "antiapoptosis-inducing factor (AIF) antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Chemicon"

Phrase: ")"

Phrase: ","

Phrase: "mouse anti8-hydroxyl-2'-deoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-OHdG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Genox,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515194:Genox [Organic Chemical,Pharmacologic Substance]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD),"

Phrase: "rabbit anti-PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1538577:PARP [Gene or Genome]
   827   C1709384:PARP [Gene or Genome]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "Diagnostic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011900:Diagnostic [Finding]
  1000   C0348026:Diagnostic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mouse anti-Fas antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(BD Biosciences"

Phrase: ")"

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "counterstained."
Processing 00000000.tx.97: The frequencies of Fas- and 8-OHdGpositive cells were obtained from each hippocampal sector. 

Phrase: "The frequencies of Fas-"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "8-OHdGpositive cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "obtained from each hippocampal sector."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   760   C1301820:Obtained [Functional Concept]
   760   C1708237:Sector [Geographic Area]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.98: In vitro studies. 

Phrase: "In vitro studies."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.99: Human neuroblastoma cells (SH-SY5Y) were grown as previously described (34). 

Phrase: "Human neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0427861:Human cells [Laboratory or Test Result]
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(SH-SY5Y"

Phrase: ")"

Phrase: "were"

Phrase: "grown as previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.100: Cells were serum starved for 1 day and then incubated with 5 or 50 mmol/l glucose with or without 3.0 nmol/l human C-peptide and/or 4 nmol/l insulin for 2 and 24 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved for 1 day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   737   C2348531:Starve [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "50 mmol/l glucose with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or without 3.0 nmol/l human C-peptide"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0439282:nmol/L [Quantitative Concept]
   762 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   762   C0607868:peptide L [Amino Acid, Peptide, or Protein]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0086418:Human [Human]
   742   C0439191:NMOLE [Quantitative Concept]

Phrase: "and/or"

Phrase: "4 nmol/l insulin for 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.101: For Western blot analyses, protein was extracted as previously described (34). 

Phrase: "For Western blot analyses,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "extracted as previously"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.102: The blots were blocked overnight at 4C with TBS saline and 0.1% (vol/vol) Tween 20 containing 5% nonfat dry milk. 

Phrase: "The blots"

Phrase: "were"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "with TBS saline"

Phrase: "and"

Phrase: "0.1%"

Phrase: "(vol/vol) Tween 20"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   812   C0449468:VOL [Quantitative Concept]
   812   C0560268:vol% [Quantitative Concept]
   812   C1690016:% vol [Qualitative Concept]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% nonfat dry milk."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0026131:Milk [Body Substance]
   812   C0349374:Milk [Food]
   812   C0444318:Milk [Substance]
   812   C2825079:Milk [Food]
   756 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   756 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   741 E C0443260:Milky [Finding]
Processing 00000000.tx.103: They were then incubated for 1 h at room temperature with blocking solution containing rabbit anti-PARP antibody (Roche Diagnostic), followed by incubation with a secondary antibody conjugated to horseradish peroxidase (Santa Cruz) for 1 h at room temperature. 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with blocking solution containing rabbit anti-PARP antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   893   C0282682:Blocking antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   845   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   829   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "Diagnostic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011900:Diagnostic [Finding]
  1000   C0348026:Diagnostic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with a secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "conjugated to horseradish peroxidase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0522529:Conjugated [Spatial Concept]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(Santa Cruz"

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.104: After washing three times in TBS Tween at room temperature, signals were detected by electrochemiluminescence (Amersham Pharmacia Biotech) and exposed to Kodak X-OMAT blue film. 

Phrase: "After"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "three times in TBS Tween"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "at room temperature, signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1710082:Signal [Phenomenon or Process]
   734   C2348236:ROOM TEMPERATURE [Qualitative Concept]

Phrase: "were"

Phrase: "detected by electrochemiluminescence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "and"

Phrase: "exposed to Kodak X-OMAT blue film."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0332157:Exposed to [Clinical Attribute]
           Exposed
   748   C0086296:Film [Manufactured Object]
   748   C1260957:Blue [Qualitative Concept]
   748   C1561571:film [Biomedical or Dental Material]
   748   C1561572:film [Substance]
Processing 00000000.tx.105: Four experiments were performed at each time point.  

Phrase: "Four experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed at each time point."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.106: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The clinical data are summarized in Table 1. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The clinical data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1516606:Clinical Data [Intellectual Product]
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "summarized in Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.107: Eight-month diabetic BB/Wor rats showed a 24% (P < 0.001) reduction in body weight. 

Phrase: "Eight-month diabetic BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0034699:Rats, BB [Mammal]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 24%"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "reduction in body weight."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0043096:Weight Reduction [Finding]
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.108: Blood glucose and HbA1c levels were significantly (both P < 0.001) increased in untreated BB/Wor rats. 

Phrase: "Blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "HbA1c levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "("

Phrase: "both P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increased in untreated BB/Wor rats."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0034699:Rats, BB [Mammal]
   753   C0004739:BB [Geographic Area]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332155:untreated [Finding]
   753   C0332297:BB [Spatial Concept]
   753   C0442805:Increased [Functional Concept]
Processing 00000000.tx.109: C-peptide replacement had no effect on body weight, blood glucose, or HbA1c values. 

Phrase: "C-peptide replacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "no effect on body weight,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "blood glucose,"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "or"

Phrase: "HbA1c values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.110: Plasma insulin and C-peptide levels were severely depleted (P < 0.001) in BB/Wor rats. 

Phrase: "Plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "C-peptide levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0202100:c peptide levels [Laboratory Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.111: C-peptide replacement had no effect on plasma insulin but completely restored plasma C-peptide levels. 

Phrase: "C-peptide replacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "no effect on plasma insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "completely restored plasma C-peptide levels."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0202100:c peptide levels [Laboratory Procedure]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.112: Systemic IGF-1 levels were significantly (P < 0.001) decreased in BB/Wor rats with no C-peptide effects. 

Phrase: "Systemic IGF-1 levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "decreased in BB/Wor rats"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C0034699:Rats, BB [Mammal]
   760   C0004739:BB [Geographic Area]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0332297:BB [Spatial Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "with no C-peptide effects."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.113: View this table: [in this window] [in a new window]  TABLE 1 Body weight, blood glucose, HbA1c, plasma insulin, C-peptide, and IGF-1 levels in control, BB/Wor and C-peptidereplaced BB/Wor rats  The effect of C-peptide on cognitive function. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Body weight,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0005910:Body Weight [Organism Attribute]
           weight
   861   C1305866:body weight [Diagnostic Procedure]
           weight
   812   C0043100:Weight [Quantitative Concept]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   812   C1705104:Weight [Idea or Concept]
   729 E C1995017:Bodies [Cell Component]

Phrase: "blood glucose,"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "HbA1c,"

Phrase: "plasma insulin,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "C-peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "IGF-1 levels in control,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0456947:Level 1 [Intellectual Product]
   760   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "BB/Wor"

Phrase: "and"

Phrase: "C-peptidereplaced BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "The effect of C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on cognitive function."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0392335:cognitive function [Mental Process]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1516691:Cognitive [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.114: Morris water maze latencies in diabetic BB/Wor rats were significantly prolonged in all four quadrants (Table 2). 

Phrase: "Morris water maze latencies in diabetic BB/Wor rats"

Phrase: "were"

Phrase: "significantly"

Phrase: "prolonged in all four quadrants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0439738:Four quadrants [Spatial Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C0439590:Prolonged [Temporal Concept]
   726   C1631280:Quadrant [Spatial Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: In C-peptidereplaced BB/Wor rats, the latencies in quadrants Q1, Q2, and Q4 were not significantly different from control animals, whereas the latency in quadrant Q3 was improved (P < 0.005) but remained prolonged (P < 0.01) compared with control rats. 

Phrase: "In C-peptidereplaced BB/Wor rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "the latencies in quadrants Q1,"

Phrase: "Q2,"

Phrase: "and"

Phrase: "Q4"

Phrase: "were"

Phrase: "not significantly different from control animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "whereas"

Phrase: "the latency in quadrant Q3"

Phrase: "was"

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "(P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "but"

Phrase: "remained"

Phrase: "prolonged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439590:Prolonged [Temporal Concept]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with control rats."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.116: View this table: [in this window] [in a new window]  TABLE 2 Latencies in seconds from the four quadrants of the Morris water maze in control, BB/Wor, and C-peptidereplaced BB/Wor rats  Hippocampal neuronal apoptosis, nucleosomal DNA laddering, and neuronal loss. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Latencies in seconds"

Phrase: "from the four quadrants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439738:Four quadrants [Spatial Concept]
   827   C1631280:Quadrant [Spatial Concept]

Phrase: "of the Morris water maze"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0083355:MAZE [Therapeutic or Preventive Procedure]
   827   C0599638:WATER [Substance]
   827   C0870866:maze [Manufactured Object]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: "in control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "BB/Wor,"

Phrase: "and"

Phrase: "C-peptidereplaced BB/Wor rats  Hippocampal neuronal apoptosis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0162638:Apoptosis [Cell Function]
   776   C1660771:neuron apoptosis [Cell Function]
   721 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "nucleosomal DNA laddering,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0336762:laddering [Manufactured Object]

Phrase: "and"

Phrase: "neuronal loss."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1850496:Neuronal loss [Finding]
   964 E C0598940:neuron loss [Finding]
   861   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.117: No TUNEL-positive neurons were detected in either hippocampal sector in control rats. 

Phrase: "No TUNEL-positive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "detected in either hippocampal sector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1708237:Sector [Geographic Area]

Phrase: "in control rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.118: TUNEL-positive neurons in untreated 8-month BB/Wor rats accounted for 3.9  1.0% (P < 0.001) of CA1 neurons and 0.6  0.4% (P < 0.05) in CA2, whereas CA3 and CA4 contained no TUNEL-positive neurons. 

Phrase: "TUNEL-positive neurons in untreated 8-month BB/Wor rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0027882:Neurons [Cell]

Phrase: "accounted for 3.9  1.0%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1551359:account [Idea or Concept]
   719   C2741673:Account # [Clinical Attribute]
   719   C2981730:Account [Classification]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "of CA1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "0.6  0.4%"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in CA2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "CA3"

Phrase: "and"

Phrase: "CA4"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "no TUNEL-positive neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.119: In C-peptidereplaced rats, 0.9  0.4% CA1 neurons were TUNEL-positive (P < 0.001 vs. BB/Wor rats) and 0% were TUNEL-positive in CA2CA4. 

Phrase: "In C-peptidereplaced rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "0.9  0.4% CA1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "TUNEL-positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: ")"

Phrase: "and"

Phrase: "0%"

Phrase: "were"

Phrase: "TUNEL-positive in CA2CA4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.120: The proapoptoic protein Bax was increased 2.5-fold (P < 0.01) in hippocampi of untreated BB/Wor rats and by an insignificant amount (20%) in C-peptidereplaced BB/Wor rats. 

Phrase: "The proapoptoic protein Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0812198:BAX [Gene or Genome]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "of untreated BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0034699:Rats, BB [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "and by an insignificant amount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1265611:Amount [Quantitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "(20%"

Phrase: ")"

Phrase: "in C-peptidereplaced BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
Processing 00000000.tx.121: The Bax expression in the latter was significantly (P < 0.05) less than in nonC-peptidereplaced BB/Wor rats (Fig. 1A). 

Phrase: "The Bax expression in the latter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "less than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439092:Less Than [Intellectual Product]
           less
   833   C0547044:Less [Qualitative Concept]

Phrase: "in nonC-peptidereplaced BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.122: Bcl-xL expression, on the other hand, was not altered in either experimental group (Fig. 1B). 

Phrase: "Bcl-xL expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered in either experimental group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0392747:Altered [Functional Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1517586:Experimental [Qualitative Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: View larger version (22K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.124: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.125: The protein expression of Bax (A) and Bcl-xL (B) in hippocampi in four individual animals per group. 

Phrase: "The protein expression of Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1171362:protein expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(A)"

Phrase: "and"

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "(B) in hippocampi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347469:/B [Quantitative Concept]

Phrase: "in four individual animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "per group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.126: Bax was significantly (P < 0.01) increased in BB/Wor rats. 

Phrase: "Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increased in BB/Wor rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0034699:Rats, BB [Mammal]
   760   C0004739:BB [Geographic Area]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332297:BB [Spatial Concept]
   760   C0442805:Increased [Functional Concept]
Processing 00000000.tx.127: C-peptide replacement significantly (P < 0.05) prevented this increase. 

Phrase: "C-peptide replacement significantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1555302:Replacement [Idea or Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "this increase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
Processing 00000000.tx.128: Bcl-xL was not altered in any of the diabetic groups. 

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered in any of the diabetic groups."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0241863:DIABETIC [Finding]
   748   C0392747:Altered [Functional Concept]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1552839:groups [Idea or Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
Processing 00000000.tx.129: *P < 0.01 vs. controls; 

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.130: P < 0.05 vs. 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.131: BB/Wor rats.  

Phrase: "BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.132: Caspase 3 is activated via several apoptotic pathways, including perturbed tyrosine kinase signaling, Fas activation via caspase 8, mitochondrial and endoplasmic reticulum dysfunction, and caspase 12. 

Phrase: "Caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "activated via several apoptotic pathways,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C1516044:Apoptotic [Qualitative Concept]
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
   760   C1879547:Activated [Activity]
   754   C0162638:Apoptosis Pathway [Cell Function]
   726 E C1515877:Activate [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "perturbed tyrosine kinase signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "Fas activation via caspase 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026237:Mitochondrial [Cell Component]
  1000   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "endoplasmic reticulum dysfunction,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "and"

Phrase: "caspase 12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0911469:Caspase 12 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.133: The expression of active caspase 3 was increased by 50% (P < 0.05) in BB/Wor rats but was unchanged in C-peptidereplaced diabetic rats (Fig. 2A). 

Phrase: "The expression of active caspase 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "increased by 50%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "but"

Phrase: "was"

Phrase: "unchanged in C-peptidereplaced diabetic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0442739:Unchanged [Finding]
   753   C2346711:Unchanged [Qualitative Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.134: These findings corresponded to nucleosomal DNA laddering in 8-month BB/Wor rats, which was not evident in control or C-peptidereplaced BB/Wor rats (Fig. 2B). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "corresponded to nucleosomal DNA laddering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0336762:laddering [Manufactured Object]

Phrase: "in 8-month BB/Wor rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "which"

Phrase: "was"

Phrase: "not evident in control"

Phrase: "or"

Phrase: "C-peptidereplaced BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.135: View larger version (30K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.136: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.137: A: The expression of active caspase 3 was significantly (P < 0.05) increased in BB/Wor rats but not in C-peptidereplaced BB/Wor rats. 

Phrase: "A"

Phrase: ":"

Phrase: "The expression of active caspase 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increased in BB/Wor rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0034699:Rats, BB [Mammal]
   760   C0004739:BB [Geographic Area]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332297:BB [Spatial Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "but"

Phrase: "not in C-peptidereplaced BB/Wor rats."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0034699:Rats, BB [Mammal]
   748   C0004739:BB [Geographic Area]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0332297:BB [Spatial Concept]
   748   C1518422:Not [Functional Concept]
Processing 00000000.tx.138: Data represent four experiments per animal group. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "four experiments per animal group."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0205664:Animal Experiments [Research Activity]
   760   C0681814:Experiments [Research Activity]
   756 E C0003064:experimental animal [Animal]
   726 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.139: B: DNA laddering is clearly visible in hippocampi of BB/Wor rats but not in those of control or C-peptidereplaced BB/Wor rats. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "DNA laddering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336762:laddering [Manufactured Object]

Phrase: "is"

Phrase: "clearly visible in hippocampi of BB/Wor rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205379:Visible [Qualitative Concept]

Phrase: "but"

Phrase: "not in those of control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "C-peptidereplaced BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
Processing 00000000.tx.140: *P < 0.05 vs. controls.  

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.141: The densities of pyramidal cell neurons were significantly decreased in CA1 (P < 0.001) and CA2 (P < 0.05) but not in CA3 and CA4 in untreated BB/Wor rats (Fig. 3). 

Phrase: "The densities of pyramidal cell neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0162339:Densities, Cell [Quantitative Concept]
   753   C0178587:densities [Quantitative Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased in CA1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "CA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "but"

Phrase: "not in CA3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "and"

Phrase: "CA4 in untreated BB/Wor rats"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.142: C-peptide replacement resulted in a significant (P < 0.05) protection of neuronal loss in CA1, which, however, was still significantly (P < 0.01) greater than in control rats. 

Phrase: "C-peptide replacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulted in a significant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "protection of neuronal loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "in CA1,"

Phrase: "which,"

Phrase: "however,"

Phrase: "was"

Phrase: "still significantly"

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "greater than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439093:Greater Than [Quantitative Concept]
   833   C0443228:greater [Quantitative Concept]
   833   C1704243:Greater [Quantitative Concept]
   799 E C0549177:Great [Quantitative Concept]

Phrase: "in control rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.143: In CA2, it was not significantly different from the density in control rats (Fig. 3). 

Phrase: "In CA2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "it"

Phrase: "was"

Phrase: "not significantly different from the density"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "in control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.144: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.146: Neuronal densities in CA1CA4 in four hippocampi from each control, BB/Wor, and C-peptidereplaced BB/Wor rat. 

Phrase: "Neuronal densities in CA1CA4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178587:densities [Quantitative Concept]

Phrase: "in four hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "from each control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "BB/Wor,"

Phrase: "and"

Phrase: "C-peptidereplaced BB/Wor rat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rat, BB [Mammal]
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
Processing 00000000.tx.147: In CA1 and CA2 of BB/Wor rats neuronal densities were significantly (P < 0.001 and P < 0.05, respectively) decreased. 

Phrase: "In CA1"

Phrase: "and"

Phrase: "CA2 of BB/Wor rats neuronal densities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")"

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.148: C-peptide replacement resulted in a significant (P < 0.05) protection against neuronal loss in CA1, which, however, was still significantly greater (P < 0.01) than in control rats. 

Phrase: "C-peptide replacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulted in a significant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "protection against neuronal loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "in CA1,"

Phrase: "which,"

Phrase: "however,"

Phrase: "was"

Phrase: "still significantly greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0443228:greater [Quantitative Concept]
   827   C1704243:Greater [Quantitative Concept]
   793 E C0549177:Great [Quantitative Concept]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "than"

Phrase: "in control rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.149: In CA2, it was not significantly greater than in control rats. 

Phrase: "In CA2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "it"

Phrase: "was"

Phrase: "not significantly greater than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "in control rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.150: No significant differences existed between the groups in CA3 and CA4. 

Phrase: "No significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "existed between the groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C2987476:Exist [Conceptual Entity]

Phrase: "in CA3"

Phrase: "and"

Phrase: "CA4."
Processing 00000000.tx.151: **P < 0.001; 

Phrase: "*"

Phrase: "*P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.152: *P < 0.01, P < 0.05 vs. controls; 

Phrase: "*P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.153: P < 0.05 vs. 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.154: BB/Wor rats.  

Phrase: "BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.155: The effect of C-peptide on tyrosine kinase receptors and their ligands. 

Phrase: "The effect of C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on tyrosine kinase receptors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0206364:Tyrosine Kinase Receptors [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C0072482:Tyrosine Kinase Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C0919487:TYROSINE KINASE RECEPTOR [Gene or Genome]
   913   C0255618:tyrosine receptors [Amino Acid, Peptide, or Protein,Receptor]
   901   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "their ligands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]
Processing 00000000.tx.156: Expression of hippocampal insulin receptor was decreased by 63% (P < 0.001) in BB/Wor rats. 

Phrase: "Expression of hippocampal insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0597360:receptor expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "decreased by 63%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.157: C-peptide replacement partially prevented (P < 0.05) insulin receptor expression, which, however, remained less (P < 0.05) than in control rats (Fig. 4A). 

Phrase: "C-peptide replacement partially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1555302:Replacement [Idea or Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "insulin receptor expression,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597360:receptor expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "which,"

Phrase: "however,"

Phrase: "remained"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "than"

Phrase: "in control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.158: IGF insulin receptor expression was decreased by 50% (P < 0.001) in untreated BB/Wor rats and by 31% (P < 0.01) in C-peptidereplaced rats, resulting in a significant (P < 0.05) protection (Fig. 4B). 

Phrase: "IGF insulin receptor expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0597360:receptor expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   708   C0140079:IGF Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "decreased by 50%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in untreated BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0034699:Rats, BB [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "and by 31%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450355:31 [Intellectual Product]
   790   C1515981:And [Idea or Concept]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in C-peptidereplaced rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "resulting in a significant"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332294:Resulting in [Functional Concept]
   770   C0237881:significant [Quantitative Concept]
   770   C0678226:resulting [Functional Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.159: Endogenous hippocampal IGF-1 and -2 were significantly (P < 0.05 and P < 0.001, respectively) decreased in BB/Wor rats. 

Phrase: "Endogenous hippocampal IGF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "were"

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")"

Phrase: "decreased in BB/Wor rats."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C0034699:Rats, BB [Mammal]
   760   C0004739:BB [Geographic Area]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0332297:BB [Spatial Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.160: C-peptide replenishment prevented the decreased IGF-1 expression and partially decreased (P < 0.05) that of IGF-2 expression (Figs. 4C and D). 

Phrase: "C-peptide replenishment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the decreased IGF-1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "partially"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "that of IGF-2 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0021666:IGF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Figs. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.161: Total endogenous hippocampal NGF was significantly (P < 0.01) decreased in BB/Wor rats but not in C-peptidereplaced rats (Fig. 5A). 

Phrase: "Total endogenous hippocampal NGF"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   861   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0027740:Nerve [Tissue]
   799   C0027757:NERVE [Tissue]
   799   C0220844:growth [Physiologic Function]
   799   C0814002:Neural Growth [Cell Function,Organism Function]
   799   C1280541:Nerve [Body Part, Organ, or Organ Component]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0599851:Neural [Functional Concept]
   727 E C0027769:nervy [Sign or Symptom]

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "decreased in BB/Wor rats"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C0034699:Rats, BB [Mammal]
   760   C0004739:BB [Geographic Area]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0332297:BB [Spatial Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "not in C-peptidereplaced rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C1518422:Not [Functional Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.162: NGFR TrA expression was similarly decreased (P < 0.05) in BB/Wor rats but not in C-peptidereplaced rats (Fig. 5B). 

Phrase: "NGFR TrA expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C0597360:receptor expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0254837:Receptor, Nerve Growth Factor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]

Phrase: "was"

Phrase: "similarly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "but"

Phrase: "not in C-peptidereplaced rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C1518422:Not [Functional Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.163: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.164: 4. 

Phrase: "4."
Processing 00000000.tx.165: Protein expression of insulin receptor (A), IGF insulin receptor (IGF-IR) (B), IGF-1 (C), and IGF-2 (D) in hippocampi from four animals per experimental group. 

Phrase: "Protein expression of insulin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1171362:protein expression [Genetic Function]
   797   C0597360:receptor expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "IGF insulin receptor (IGF-IR)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C0140079:IGF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "IGF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "IGF-2 ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021666:IGF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "D) in hippocampi"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   790   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0949582:Hippocampus [Fish]
   790   C1029104:Hippocampus [Fish]
   790   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "from four animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "per experimental group."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1517586:Experimental [Qualitative Concept]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.166: Insulin receptor (A) was significantly (P < 0.001) decreased in BB/Wor rats. 

Phrase: "Insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(A)"

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "decreased in BB/Wor rats."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C0034699:Rats, BB [Mammal]
   760   C0004739:BB [Geographic Area]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0332297:BB [Spatial Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.167: C-peptide replacement significantly prevented (P < 0.05) this decrease, which, however, was still significant (P < 0.05) compared with control rats. 

Phrase: "C-peptide replacement significantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1555302:Replacement [Idea or Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "this decrease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "which,"

Phrase: "however,"

Phrase: "was"

Phrase: "still significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with control rats."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.168: IGF-1 receptor (B) showed a similar decrease (P < 0.005) in BB/Wor rats that was partially prevented (P < 0.05) by C-peptide replacement. 

Phrase: "IGF-1 receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0140080:IGF-1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   913   C0140079:IGF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a similar decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "(P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "that"

Phrase: "was"

Phrase: "partially"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "by C-peptide replacement."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.169: Endogenous IGF-1 (C) and IGF-2 (D) were both suppressed in hippocampi of BB/Wor rats (P < 0.05 and P < 0.001, respectively). 

Phrase: "Endogenous IGF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "IGF-2 ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021666:IGF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "D)"

Phrase: "were"

Phrase: "both"

Phrase: "suppressed in hippocampi of BB/Wor rats"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C0034699:Rats, BB [Mammal]
   748   C0004739:BB [Geographic Area]
   748   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0332297:BB [Spatial Concept]
   748   C0949582:Hippocampus [Fish]
   748   C1029104:Hippocampus [Fish]
   748   C1260953:Suppressed [Functional Concept]
   748   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.170: IGF-1 was completely prevented by C-peptide replacement, whereas this effect was only partial (P < 0.05) with respect to IGF-2. 

Phrase: "IGF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "prevented by C-peptide replacement,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0035139:Replacement [Therapeutic or Preventive Procedure]
   760   C0559956:Replacement [Functional Concept]
   760   C1555302:Replacement [Idea or Concept]
   726   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "whereas"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "only partial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0728938:Partial [Quantitative Concept]
   861   C1550516:partial [Idea or Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "with respect to IGF-2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021666:IGF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.171: *P < 0.001, **P < 0.005, P < 0.05 vs. controls; 

Phrase: "*P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "*P < 0.005,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.172: < 0.05 vs. controls; 

Phrase: "< 0.05"

Phrase: "vs. controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.173: P < 0.05 vs. 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.174: BB/Wor rats.  

Phrase: "BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.175: View larger version (22K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.176: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.177: Hippocampal expression of NGF (A) and NGFR tryosine receptor kinase A (TrkA) (B) in four control, BB/Wor- and C-peptidereplaced BB/Wor rats. 

Phrase: "Hippocampal expression of NGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(A)"

Phrase: "and"

Phrase: "NGFR tryosine receptor kinase A (TrkA) (B)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   866   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   866   C1824728:FACTOR B [Gene or Genome]

Phrase: "in four control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "BB/Wor-"

Phrase: "and"

Phrase: "C-peptidereplaced BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
Processing 00000000.tx.178: NGF expression (A) was significantly (P < 0.01) suppressed in BB/Wor rats but not in C-peptidereplenished rats. 

Phrase: "NGF expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(A)"

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "suppressed in BB/Wor rats"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0034699:Rats, BB [Mammal]
   760   C0004739:BB [Geographic Area]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0332297:BB [Spatial Concept]
   760   C1260953:Suppressed [Functional Concept]

Phrase: "but"

Phrase: "not in C-peptidereplenished rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C1518422:Not [Functional Concept]
Processing 00000000.tx.179: The high affinity NGFR-tryosine receptor kinase A (B) was also suppressed (P < 0.05) in BB/Wor rats, which was prevented by C-peptide replacement. 

Phrase: "The high affinity NGFR-tryosine receptor kinase A (B)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   850   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   850   C1824728:FACTOR B [Gene or Genome]
   704   C0072482:High Affinity Nerve Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   704   C0919487:high affinity nerve growth factor receptor [Gene or Genome]

Phrase: "was"

Phrase: "also"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in BB/Wor rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "which"

Phrase: "was"

Phrase: "prevented by C-peptide replacement."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0035139:Replacement [Therapeutic or Preventive Procedure]
   760   C0559956:Replacement [Functional Concept]
   760   C1555302:Replacement [Idea or Concept]
   726   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.180: *P < 0.01, P < 0.05 vs. control rats.  

Phrase: "*P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.181: The effect of C-peptide on Fas and NGFR p75 expression. 

Phrase: "The effect of C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on Fas"

Phrase: "and"

Phrase: "NGFR p75 expression."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C0597360:receptor expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   780   C0254837:Nerve Growth Factor Receptor p75 [Amino Acid, Peptide, or Protein,Receptor]
           Receptor, Nerve Growth Factor
   734   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]
Processing 00000000.tx.182: NGFR p75 is the original member of the Fas/tumor necrosis factor (TNF) receptor family known for its role in apoptosis (41). 

Phrase: "NGFR p75"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0254837:Nerve Growth Factor Receptor p75 [Amino Acid, Peptide, or Protein,Receptor]
           Receptor, Nerve Growth Factor
   771   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]
   717   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "the original member of the Fas/tumor necrosis factor (TNF) receptor family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0086282:Family member [Family Group]
   754   C1611821:Family Member [Intellectual Product]
   738   C0680022:member [Population Group]
   738   C2698041:Member [Professional or Occupational Group]

Phrase: "known for its role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035820:Role [Social Behavior]
   770   C0205309:Known [Qualitative Concept]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.183: The NGFR p75 expression was increased 2.2-fold (P < 0.05) in the hippocampi of BB/Wor rats. 

Phrase: "The NGFR p75 expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C0597360:receptor expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   780   C0254837:Nerve Growth Factor Receptor p75 [Amino Acid, Peptide, or Protein,Receptor]
           Receptor, Nerve Growth Factor
   734   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2.2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in the hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "of BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.184: C-peptide replacement fully (P < 0.05) prevented this increase (Fig. 6A). 

Phrase: "C-peptide replacement fully"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035139:Replacement [Therapeutic or Preventive Procedure]
   812   C0559956:Replacement [Functional Concept]
   812   C1555302:Replacement [Idea or Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "this increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.185: The expression of Fas was significantly (P < 0.05) increased in BB/Wor rats and was not effected by C-peptide replacement (Fig. 6B). 

Phrase: "The expression of Fas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increased in BB/Wor rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0034699:Rats, BB [Mammal]
   760   C0004739:BB [Geographic Area]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332297:BB [Spatial Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "effected by C-peptide replacement"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0035139:Replacement [Therapeutic or Preventive Procedure]
   760   C0559956:Replacement [Functional Concept]
   760   C1555302:Replacement [Idea or Concept]
   726   C1280500:Effect [Qualitative Concept]
   726   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.186: However, distinct Fas immunostaining was evident in 4.8  1.1% (P < 0.001) of CA1 neurons in BB/Wor rats and 0.4  0.3% (P < 0.001 vs. BB/Wor rats) in C-peptidereplaced diabetic rats. 

Phrase: "However,"

Phrase: "distinct Fas immunostaining"

Phrase: "was"

Phrase: "evident in 4.8  1.1%"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "of CA1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "0.4  0.3%"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: ")"

Phrase: "in C-peptidereplaced diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]
Processing 00000000.tx.187: No positive staining was detected in control rats (Fig. 6C). 

Phrase: "No positive staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "detected in control rats"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.188: View larger version (34K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.189: 6. 

Phrase: "6."
Processing 00000000.tx.190: The expression of NGFR P75 (A) and Fas (B) were both significantly (P < 0.05) increased in BB/Wor rat hippocampi. 

Phrase: "The expression of NGFR P75"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   703   C0254837:Nerve Growth Factor Receptor p75 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(A)"

Phrase: "and"

Phrase: "Fas ("

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "both significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increased in BB/Wor rat hippocampi."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0034699:Rat, BB [Mammal]
   753   C0004739:BB [Geographic Area]
   753   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0205217:Increased [Quantitative Concept]
   753   C0332297:BB [Spatial Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0949582:Hippocampus [Fish]
   753   C1029104:Hippocampus [Fish]
   753   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.191: The increase in NGFR P75 (A) was fully (P < 0.05) prevented by C-peptide replacement. 

Phrase: "The increase in NGFR P75"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0442805:Increase [Functional Concept]
   703   C0254837:Nerve Growth Factor Receptor p75 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(A)"

Phrase: "was"

Phrase: "fully"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "prevented by C-peptide replacement."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0035139:Replacement [Therapeutic or Preventive Procedure]
   760   C0559956:Replacement [Functional Concept]
   760   C1555302:Replacement [Idea or Concept]
   726   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.192: Fas expression was not effect by C-peptide replacement. 

Phrase: "Fas expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not effect by C-peptide replacement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.193: Immunostaining of Fas (C) in CA1 revealed occasional (4.8% of neurons) nuclear staining in BB/Wor rats. 

Phrase: "Immunostaining of Fas (C) in CA1"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "occasional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521114:Occasional [Temporal Concept]

Phrase: "(4.8% of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: ")"

Phrase: "nuclear staining in BB/Wor rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
Processing 00000000.tx.194: This was substantially (P < 0.001) less (0.4%) in C-peptidereplaced animals and was absent in control rats. 

Phrase: "This"

Phrase: "was"

Phrase: "substantially"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "(0.4%"

Phrase: ")"

Phrase: "in C-peptidereplaced animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "was"

Phrase: "absent in control rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]
Processing 00000000.tx.195: Magnification x150. 

Phrase: "Magnification x150."
Processing 00000000.tx.196: *P < 0.05 vs. controls; 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.197: P < 0.05 vs. 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.198: BB/Wor rats.  

Phrase: "BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.199: The effect of C-peptide on PARP activities and oxidative stressinduced DNA damage. 

Phrase: "The effect of C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on PARP activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "oxidative stressinduced DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   812   C0010957:Damage [Injury or Poisoning]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1883709:Damage [Functional Concept]
Processing 00000000.tx.200: PARP was expressed in the nuclei of CA1 hippocampal neurons in BB/Wor rats. 

Phrase: "PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: "was"

Phrase: "expressed in the nuclei of CA1 hippocampal neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   744   C0027882:Neurons [Cell]
   725   C3146324:neuronal nuclei [Gene or Genome]
   711   C0007610:Nucleus [Cell Component]

Phrase: "in BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.201: This was markedly less in C-peptidereplaced rats and absent in control rats (Fig. 7A). 

Phrase: "This"

Phrase: "was"

Phrase: "markedly less in C-peptidereplaced rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0522501:Markedly [Qualitative Concept]

Phrase: "and"

Phrase: "absent in control rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.202: The expression of cleaved PARP (89 kDa), a marker of apoptosis (42), was increased 4.3-fold (P < 0.001) in diabetic BB/Wor rats vs. 

Phrase: "The expression of cleaved PARP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(89 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a marker of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005516:Marker [Clinical Attribute]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "4.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in diabetic BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0034699:Rats, BB [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "vs."
Processing 00000000.tx.203: 2.0-fold (P < 0.05) in C-peptidereplaced rats (Fig. 7B), which was significantly (P < 0.05) less than in BB/Wor rats. 

Phrase: "2.0-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in C-peptidereplaced rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(Fig. 7B"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "less than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439092:Less Than [Intellectual Product]
           less
   833   C0547044:Less [Qualitative Concept]

Phrase: "in BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.204: View larger version (44K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.205: 7. 

Phrase: "7."
Processing 00000000.tx.206: Immunostaining of PARP (A) showed frequent nuclear immunoreactivity in CA1 of BB/Wor rats. 

Phrase: "Immunostaining of PARP"

Phrase: "(A)"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "frequent nuclear immunoreactivity in CA1 of BB/Wor rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.207: This was less common in CA1 of C-peptidereplaced BB/Wor rats and was not observed in control rats. 

Phrase: "This"

Phrase: "was"

Phrase: "less common in CA1 of C-peptidereplaced BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205214:Common [Quantitative Concept]
   739   C1522138:Common [Functional Concept]
   739   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in control rats."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.208: Magnification x180. 

Phrase: "Magnification x180."
Processing 00000000.tx.209: This corresponded to increased (P < 0.001) expression of cleaved PARP in BB/Wor rats, which was significantly (P < 0.05) but not fully (P < 0.05) prevented by C-peptide. 

Phrase: "This"

Phrase: "corresponded to increased"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "expression of cleaved PARP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in BB/Wor rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "which"

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "but"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "prevented by C-peptide."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   819 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   737   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.210: Immunostaining of 8-OHdG (C) reflecting ROS-induced DNA damage was present in 2.7% (P < 0.05) of CA1 neuronal nuclei in BB/Wor rats and to a significantly (P < 0.05; 0.1%) lesser extent in C-peptidereplaced rats. 

Phrase: "Immunostaining of 8-OHdG"

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "ROS-induced DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   799   C0010957:Damage [Injury or Poisoning]
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1883709:Damage [Functional Concept]

Phrase: "was"

Phrase: "present in 2.7%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "of CA1 neuronal nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C3146324:neuronal nuclei [Gene or Genome]
   793   C0007610:Nucleus [Cell Component]

Phrase: "in BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "and to a significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; 0.1%"

Phrase: ")"

Phrase: "lesser extent in C-peptidereplaced rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]
Processing 00000000.tx.211: Magnification x150. 

Phrase: "Magnification x150."
Processing 00000000.tx.212: *P < 0.001, P < 0.05 vs. control rats; 

Phrase: "*P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.213: P < 0.05 vs. 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.214: BB/Wor rats.  

Phrase: "BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.215: 8-OHdG is a specific marker for reduced oxygen speciesinduced DNA damage (43). 

Phrase: "8-OHdG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050078:8-OHdG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "a specific marker for reduced oxygen speciesinduced DNA damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0012872:Marker, DNA [Nucleotide Sequence]
   742   C0005516:Marker [Clinical Attribute]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.216: In BB/Wor rats, nuclear 8-OHdG staining was present in 2.7  1.1% (P < 0.02) of CA1 neurons. 

Phrase: "In BB/Wor rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "nuclear 8-OHdG staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "present in 2.7  1.1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "(P < 0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "of CA1 neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.217: No nuclear 8-OHdG staining was observed in control rats (Fig. 7C), and an insignificant 0.1  0.0% was seen in C-peptidereplaced rats. 

Phrase: "No nuclear 8-OHdG staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "observed in control rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 7C"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "an insignificant 0.1  0.0%"

Phrase: "was"

Phrase: "seen in C-peptidereplaced rats."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
Processing 00000000.tx.218: Immunostaining of AIF showed occasional stippled cytosolic staining of control neurons. 

Phrase: "Immunostaining of AIF"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "occasional stippled cytosolic staining of control neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]
Processing 00000000.tx.219: In BB/Wor rats, positive AIF staining was common within neuronal nuclei, whereas in C-peptidereplaced rats, AIF positivity was confined to the neuronal cytoplasm (data not shown). 

Phrase: "In BB/Wor rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "positive AIF staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0487602:Staining [Laboratory Procedure]
   804   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "common within neuronal nuclei,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "whereas in C-peptidereplaced rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]

Phrase: "AIF positivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C0439178:% Positive [Quantitative Concept]
   741   C1446409:Positive [Qualitative Concept]
   741   C1514241:Positive [Finding]
   741   C2825490:Positive [Qualitative Concept]

Phrase: "was"

Phrase: "confined to the neuronal cytoplasm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1178979:Neuron cytoplasm [Cell Component]
   760   C0010834:Cytoplasm [Cell Component]
   760   C0521390:Neuronal [Immunologic Factor]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.220: Expression and localization of caspase 12. 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "localization of caspase 12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]
Processing 00000000.tx.221: The expression of caspase 12 emanating from endoplasmic reticulum dysfunction was increased 2.4-fold (P < 0.05) in BB/Wor rats, which was prevented in C-peptidereplaced diabetic rats (Fig. 8A). 

Phrase: "The expression of caspase 12 emanating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "from endoplasmic reticulum dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2.4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in BB/Wor rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "which"

Phrase: "was"

Phrase: "prevented in C-peptidereplaced diabetic rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0241863:DIABETIC [Finding]
   719   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.222: This was associated with increased immunostaining of caspase 12 in nuclei of CA1 neurons in BB/Wor rats. 

Phrase: "This"

Phrase: "was"

Phrase: "associated with increased immunostaining of caspase 12"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0911469:Caspase 12 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "of CA1 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rats, BB [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.223: Similar staining was not detectable in control or C-peptidereplaced rats (Fig. 8B). 

Phrase: "Similar staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "not detectable in control"

Phrase: "or"

Phrase: "C-peptidereplaced rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.224: Cleaved PARP expression in SH-SY5Y cells. 

Phrase: "Cleaved PARP expression in SH-SY5Y cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.225: View larger version (32K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.226: 8. 

Phrase: "8."
Processing 00000000.tx.227: The expression of hippocampal caspase 12 (A) was significantly (P < 0.05) increased in BB/Wor rats. 

Phrase: "The expression of hippocampal caspase 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(A)"

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increased in BB/Wor rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0034699:Rats, BB [Mammal]
   760   C0004739:BB [Geographic Area]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332297:BB [Spatial Concept]
   760   C0442805:Increased [Functional Concept]
Processing 00000000.tx.228: This was prevented by C-peptide replacement. 

Phrase: "This"

Phrase: "was"

Phrase: "prevented by C-peptide replacement."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0035139:Replacement [Therapeutic or Preventive Procedure]
   760   C0559956:Replacement [Functional Concept]
   760   C1555302:Replacement [Idea or Concept]
   726   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.229: In CA1, this corresponded to frequent immunostaining of caspase 12 (B) in neuronal nuclei, a staining pattern that was not obvious in control and C-peptidereplaced animals. 

Phrase: "In CA1,"

Phrase: "this"

Phrase: "corresponded to frequent immunostaining of caspase 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0911469:Caspase 12 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332183:Frequent [Temporal Concept]

Phrase: "(B) in neuronal nuclei,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347469:/B [Quantitative Concept]

Phrase: "a staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "that"

Phrase: "was"

Phrase: "not obvious in control"

Phrase: "and"

Phrase: "C-peptidereplaced animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]
Processing 00000000.tx.230: Magnification x150. 

Phrase: "Magnification x150."
Processing 00000000.tx.231: *P < 0.05 vs. control rats.  

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.232: After 2 h exposure to 50 mmol/l glucose, SH-SY5Y cells showed an insignificant increase in the expression of cleaved PARP (89 kDa) (data not shown). 

Phrase: "After 2 h exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "to 50 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an insignificant increase in the expression of cleaved PARP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "(89 kDa) (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.233: Following 24 h exposure, there was an 80% (P < 0.01) increase in cleaved PARP compared with cells incubated in 5 mmol/l glucose (Fig. 9). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "24 h exposure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "there"

Phrase: "was"

Phrase: "an 80%"

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "increase in cleaved PARP"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]
   770   C0442805:Increase [Functional Concept]
   770   C1538577:PARP [Gene or Genome]
   770   C1709384:PARP [Gene or Genome]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "compared with cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1707455:Compared [Activity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in 5 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.234: C-peptide alone had no effect on the elevated expression of cleaved PARP, whereas 4 nmol/l insulin resulted in a significant (P < 0.05) protection against increased cleaved PARP expression, a protection which was maximal (P < 0.01) following treatment with 3 nmol/l C-peptide and 4 nmol/l insulin (Fig. 9). 

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "had"

Phrase: "no effect on the elevated expression of cleaved PARP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "whereas"

Phrase: "4 nmol/l insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resulted in a significant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "protection against increased cleaved PARP expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1545588:Protection [Finding]

Phrase: "a protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "which"

Phrase: "was"

Phrase: "maximal"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205289:Maximal [Qualitative Concept]
  1000   C0806909:Maximal [Quantitative Concept]
   928 E C1552615:maximum [Quantitative Concept]
   928 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with 3 nmol/l C-peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "4 nmol/l insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.235: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.236: 9. 

Phrase: "9."
Processing 00000000.tx.237: Expression of cleaved PARP (89 kDa) indicative of apoptosis in human neuroblastoma (SH-SY5Y) cells incubated for 24 h in 5 mmol/l glucose (A); 

Phrase: "Expression of cleaved PARP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(89 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "indicative of apoptosis"

Phrase: "in human neuroblastoma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027819:Neuroblastoma [Neoplastic Process]
   861   C0700095:neuroblastoma [Neoplastic Process]
   861   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(SH-SY5Y"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.238: 50 mmol/l glucose (B); 

Phrase: "50 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.239: and 50 mmol/l glucose + 3 nmol/l C-peptide (C), + 4 nmol/l insulin (D), or + 3 nmol/l C-peptide and 4 nmol/l insulin (E). 

Phrase: "and"

Phrase: "50 mmol/l glucose + 3 nmol/l C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   807   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(C), + 4 nmol/l insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "D)"

Phrase: ","

Phrase: "or + 3 nmol/l C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "4 nmol/l insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.240: Fifty micromoles of glucose significantly increased (P < 0.01) 89-kDa PARP expression. 

Phrase: "Fifty micromoles of glucose significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439194:Micromole [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "89-kDa PARP expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.241: This was not effected by C-peptide alone (C) but was significantly (P < 0.05) prevented by insulin alone (D) and maximally prevented (P < 0.01) by the combination of C-peptide and insulin (E). 

Phrase: "This"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "effected by C-peptide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   819 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   737   C1280500:Effect [Qualitative Concept]
   737   C2348382:Effect [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "but"

Phrase: "was"

Phrase: "significantly"

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "prevented by insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756   C0309872:PREVENT [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "("

Phrase: "D)"

Phrase: "and"

Phrase: "maximally"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "by the combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "of C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.242: The data represent the mean  SD of four experiments.*P < 0.05, **P < 0.01 vs. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  SD of four experiments."

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.243: A; 

Phrase: "A"

Phrase: ";"
Processing 00000000.tx.244: P < 0.05, P < 0.01 vs. 

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.245: B; 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.246: P < 0.05 vs. 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.247: D; 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.248: P < 0.01 vs. 

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.249: C.   

Phrase: "C."
Processing 00000000.tx.250: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Apoptosis is common in diabetes and degenerative central nervous system disorders. 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "common in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205214:Common [Quantitative Concept]
   790   C1522138:Common [Functional Concept]
   790   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "degenerative central nervous system disorders."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   937   C0007682:Central Nervous System Disorders [Disease or Syndrome]
   914   C0524851:Degenerative Neurologic Disorders [Disease or Syndrome]
   897   C1285162:degenerative disorders [Disease or Syndrome]
   884   C0027765:Nervous System Disorders [Disease or Syndrome]
           NERVOUS DISORDERS
   836 E C0851241:nervous disorder [Mental or Behavioral Dysfunction]
   823   C1298233:system disorder [Functional Concept]
   804   C0012634:Disorders [Disease or Syndrome]
   787 E C0442893:Systemic Disorder [Disease or Syndrome]
   717   C0927232:Central Nervous System [Body System]
   717   C1269563:Central nervous system [Body System]
Processing 00000000.tx.251: It is involved in -cell loss in type 1 diabetes (44,45), occurs in diabetic retinopathy (46), and has been claimed (43,47,48) to be a prominent phenomenon in diabetic neuropathy, which, however, has not been reproduced by other investigators (49). 

Phrase: "It"

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -cell loss in type 1 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "(44,"

Phrase: "45"

Phrase: ")"

Phrase: ","

Phrase: "occurs in diabetic retinopathy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0011884:Diabetic Retinopathy [Disease or Syndrome]
   770   C0035309:Retinopathy [Disease or Syndrome]
   770   C0241863:DIABETIC [Finding]
   770   C1709305:Occur [Activity]
   770   C1962966:Retinopathy [Finding]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "claimed"

Phrase: "(43,"

Phrase: "47,"

Phrase: "48"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a prominent phenomenon in diabetic neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "which,"

Phrase: "however,"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reproduced by other investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035173:Investigators [Professional or Occupational Group]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.252: These discrepancies are due to an overreliance on TUNELstaining as an indicator of apoptosis in dorsal root ganglion neurons exceeding 30% in streptozotocin-induced diabetic rats (43,47). 

Phrase: "These discrepancies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:discrepancies [Finding]

Phrase: "are due to an overreliance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0678226:Due to [Functional Concept]
           due
   760   C1551058:Are [Quantitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "on TUNELstaining"

Phrase: "as an indicator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
  1000   C1235732:Indicator [Bird]
  1000   C1522602:Indicator [Functional Concept]

Phrase: "of apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in dorsal root ganglion neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "exceeding"

Phrase: "30% in streptozotocin-induced diabetic rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   753   C0205263:Induced [Functional Concept]
   753   C0241863:DIABETIC [Finding]

Phrase: "(43,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.253: Even the modest frequencies of TUNEL-positive neurons reported here are not likely to reflect true apoptotic cell death. 

Phrase: "Even"

Phrase: "the modest frequencies of TUNEL-positive neurons"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   748   C0439603:Frequencies [Temporal Concept]
   714 E C0376249:frequency [Quantitative Concept]
   714 E C0871396:Frequency [Quantitative Concept]
   714 E C1561548:Frequency [Qualitative Concept]
   714 E C1705502:Frequency [Quantitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "not likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "true apoptotic cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0162638:apoptotic cell death [Cell Function]
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.254: Instead, additional supportive parameters like morphometric analyses, ligation-mediated PCR assays, and indicators of apoptotic stress such as caspase 3 activity and Bax expression need to be considered to obtain an accurate assessment of apoptotic cell death, as outlined by Cheng and Zochodne (49). 

Phrase: "Instead,"

Phrase: "additional supportive parameters like morphometric analyses,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0449381:Parameters [Finding]
   719 E C0549193:Parameter [Spatial Concept]
   719 E C1704769:Parameter [Conceptual Entity]
   719 E C2350001:Parameter [Quantitative Concept]

Phrase: "ligation-mediated PCR assays,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "indicators of apoptotic stress"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0021212:Indicators [Indicator, Reagent, or Diagnostic Aid]
   737 E C1235732:Indicator [Bird]
   737 E C1522602:Indicator [Functional Concept]

Phrase: "such as caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Bax expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "an accurate assessment of apoptotic cell death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1261322:Assessment [Health Care Activity]
   748   C1516048:Assessment [Activity]

Phrase: "as"

Phrase: "outlined by Cheng"

Phrase: "and"

Phrase: "Zochodne"

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.255: We previously described a duration-related apoptotic neuronal loss in the hippocampus of type 1 BB/Wor rats (21) and type 2 BBZDR/Wor rats (22). 

Phrase: "We previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "a duration-related apoptotic neuronal loss in the hippocampus"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   849   C3554202:Neuronal loss in the hippocampus [Finding]
   764   C1850496:Neuronal loss [Finding]
   742   C1517945:Loss [Quantitative Concept]
   729 E C0598940:neuron loss [Finding]

Phrase: "of type 1 BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "(21"

Phrase: ")"

Phrase: "and"

Phrase: "type 2 BBZDR/Wor rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.256: Apoptosis in diabetes has been ascribed to hyperglycemia and oxidative stress (43,47,48), although the potential role of impaired insulin action has not been addressed (35,37). 

Phrase: "Apoptosis in diabetes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "ascribed to hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(43,"

Phrase: "47,"

Phrase: "48"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the potential role of impaired insulin action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "(35,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.257: Here we demonstrate that the replacement of insulinomimetic C-peptide protects against cognitive dysfunction and hippocampal neuronal loss by preventing several apoptotic stresses. 

Phrase: "Here"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the replacement of insulinomimetic C-peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035139:Replacement [Therapeutic or Preventive Procedure]
   753   C0559956:Replacement [Functional Concept]
   753   C1555302:Replacement [Idea or Concept]

Phrase: "protects against cognitive dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C1516691:Cognitive [Functional Concept]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "hippocampal neuronal loss by preventing several apoptotic stresses."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1850496:Neuronal loss [Finding]
   744   C1517945:Loss [Quantitative Concept]
   735 E C0598940:neuron loss [Finding]
Processing 00000000.tx.258: These effects were achieved in the absence of an effect on hyperglycemia, suggesting that diabetic cognitive dysfunction is in part caused by impaired insulin/C-peptide action. 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "achieved in the absence of an effect"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0332197:absence [Quantitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that diabetic cognitive dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "caused by impaired insulin/C-peptide action."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0221099:Impaired [Functional Concept]
   748   C0441472:Action [Functional Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3266814:Action [Activity]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.259: Insulin, proinsulin C-peptide, and IGF provide antiapoptotic effects (34,50). 

Phrase: "Insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "proinsulin C-peptide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006558:Proinsulin C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           C-Peptide
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "IGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "antiapoptotic effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "(34,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.260: Originally, it was believed that insulins apoptotic effects were mediated via the IGF-1 receptor, however, recent studies have revealed that insulin exerts its antiapoptotic effects through its own receptor via Raf-1dependent signaling (50). 

Phrase: "Originally,"

Phrase: "it"

Phrase: "was"

Phrase: "believed"

Phrase: "that insulins apoptotic effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "mediated via the IGF-1 receptor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0140080:IGF-1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   790   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0140079:IGF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "however,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its antiapoptotic effects through its own receptor"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "via Raf-1dependent signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.261: This finding is consistent with data showing that the antiapoptotic effects of insulin and/or C-peptide are mediated via PI-3 kinase stimulation, p38 activation, disinhibition of inhibitor of B, translocation of NF-B, promotion of Bcl2, and inhibition of jun NH2-terminal kinase phosphorylation (21,34). 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with data"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the antiapoptotic effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and/or"

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "mediated via PI-3 kinase stimulation,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   805 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]
   753   C2348046:Phosphatidylinositol [Lipid]

Phrase: "p38 activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "disinhibition of inhibitor of B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0234410:Disinhibition [Organ or Tissue Function]
   760   C0424296:Disinhibition [Mental or Behavioral Dysfunction]

Phrase: "translocation of NF-B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1518440:Nuclear Translocation [Molecular Function]
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "promotion of Bcl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033414:Promotion [Activity]

Phrase: "and"

Phrase: "inhibition of jun NH2-terminal kinase phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C1519062:inhibition of phosphorylation [Molecular Function]
           Phosphorylation Inhibition
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "(21,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.262: Inactivation of NF-B will have consequences on gene regulation of the TNF receptor, Bcl2, and Bcl-xL, which play important roles in apoptosis (34,51,52). 

Phrase: "Inactivation of NF-B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "will"

Phrase: "have"

Phrase: "consequences on gene regulation of the TNF receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "Bcl2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376515:BCL2 [Gene or Genome]
  1000   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Bcl-xL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "which"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "important roles in apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "(34,"

Phrase: "51,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.263: In the present study, although C-peptide replacement had significant preventive effects on the suppressed endogenous expression of insulin receptor, IGF insulin receptor, and IGF-2, it did not provide complete protection. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "although"

Phrase: "C-peptide replacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "had"

Phrase: "significant preventive effects on the suppressed endogenous expression of insulin receptor,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C1280500:effects [Qualitative Concept]
   704 E C2348382:Effect [Qualitative Concept]

Phrase: "IGF insulin receptor,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C0140079:IGF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021666:IGF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "complete protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]
Processing 00000000.tx.264: In isohyperglycemic and normoC-peptidemic type 2 BBZDR/Wor rats (22), the endogenous hippocampal insulin receptor is normal, whereas IGF insulin receptor and IGF-2 are suppressed similarly to C-peptidereplaced animals. 

Phrase: "In isohyperglycemic"

Phrase: "and"

Phrase: "normoC-peptidemic type 2 BBZDR/Wor rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "the endogenous hippocampal insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "normal,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "whereas"

Phrase: "IGF insulin receptor"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C0140079:IGF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1334133:INSULIN RECEPTOR [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021666:IGF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "are"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "similarly to C-peptidereplaced animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003062:Animals [Animal]
Processing 00000000.tx.265: This suggests that hyperglycemia or associated perturbed lipid metabolism may play contributing roles. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "or"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "perturbed lipid metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0598783:Lipid Metabolism [Molecular Function]
   901   C1517898:Lipid Metabolism [Molecular Function]
   827   C0023779:Lipid [Lipid]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "contributing roles."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035820:Roles [Social Behavior]
   827 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.266: Besides insulin (34), growth hormone and prostaglandin E2 play regulatory roles on extrahepatic IGF synthesis (53). 

Phrase: "Besides insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "growth hormone"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0037663:Growth Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0169964:Growth hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0019932:Hormone [Hormone]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "prostaglandin E2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0012472:Prostaglandin E2 [Eicosanoid,Hormone,Pharmacologic Substance]
  1000   C3538990:Prostaglandin E2 [Laboratory Procedure]
   861   C3539520:E2 [Gene or Genome]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "regulatory roles on extrahepatic IGF synthesis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.267: Prostaglandin E2 levels are significantly suppressed in neural tissue of the BB/Wor rat (54), hence providing one plausible explanation. 

Phrase: "Prostaglandin E2 levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0012472:Prostaglandin E2 [Eicosanoid,Hormone,Pharmacologic Substance]
   734   C3538990:Prostaglandin E2 [Laboratory Procedure]

Phrase: "are"

Phrase: "significantly"

Phrase: "suppressed in neural tissue of the BB/Wor rat"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0027757:Neural tissue [Tissue]
   764   C1762608:Neural tissue [Tissue]
   762   C0034699:Rat, BB [Mammal]
   742   C0004739:BB [Geographic Area]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0040300:Tissue [Tissue]
   742   C0332297:BB [Spatial Concept]
   742   C0599851:Neural [Functional Concept]
   742   C1260953:Suppressed [Functional Concept]
   742   C1547928:Tissue [Intellectual Product]

Phrase: "(54"

Phrase: ")"

Phrase: ","

Phrase: "hence"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "one plausible explanation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681841:Explanation [Intellectual Product]
Processing 00000000.tx.268: Although not known, possible insulin resistance in the central nervous system in type 2 diabetes could account for impaired IGF expression. 

Phrase: "Although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "possible insulin resistance in the central nervous system"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0021655:Insulin Resistance [Pathologic Function]
   770   C2700570:INSULIN RESISTANCE [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0237834:Resistance [Mental Process]
   744   C1514892:Resistance [Physiologic Function]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "could"

Phrase: "account for impaired IGF expression."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]
Processing 00000000.tx.269: Oxidative stress is a major factor in diabetes-related apoptosis (43,48,55). 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "a major factor in diabetes-related apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "(43,"

Phrase: "48,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.270: A multitude of mechanisms lead to oxidative stress, such as mitochondrial dysfunction, endoplasmic reticulum stress-activating caspase 12, lipid peroxidation, and receptor for advanced glycation end products activation, as well as impaired glutathion and superoxide dismutase production. 

Phrase: "A multitude of mechanisms"

Phrase: "lead to oxidative stress,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "such as mitochondrial dysfunction,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "endoplasmic reticulum stress-activating caspase 12,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   861   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   827   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0911469:Caspase 12 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   799   C0038435:Stress [Finding]
   799   C1879547:activating [Activity]
   766 E C1515877:Activate [Functional Concept]
   727 E C0231297:Stressful [Functional Concept]
   727   C0598268:Endoplasm [Cell Component]

Phrase: "lipid peroxidation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: "and"

Phrase: "receptor for advanced glycation end products activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   946   C1412278:RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS [Gene or Genome]
   774   C1514758:Receptor Activation [Cell Function]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "as well as"

Phrase: "impaired glutathion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "superoxide dismutase production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.271: Reactive oxygen species (ROS) generation and lipid peroxidation is further facilitated by Fas/TNFmediated increases in apoptotic stress (56,57). 

Phrase: "Reactive oxygen species (ROS) generation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]

Phrase: "and"

Phrase: "lipid peroxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "facilitated by Fas/TNFmediated"

Phrase: "increases in apoptotic stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   777   C0231298:Increased stress [Functional Concept]
   770   C0038435:Stress [Finding]
   770   C0442805:Increase [Functional Concept]
   770   C1516044:Apoptotic [Qualitative Concept]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "(56,"

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.272: Oxidative stress leads to apoptosis via increased ceramide (58), hyperglutamatergic activity (59), or activation of AIF, perpetuating further mitochondrial permeabilization (56,60) and mediating caspase-independent apoptosis (6062). 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "leads to apoptosis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0162638:Apoptosis [Cell Function]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "via increased ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "(58"

Phrase: ")"

Phrase: ","

Phrase: "hyperglutamatergic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(59"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "activation of AIF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "perpetuating"

Phrase: "further mitochondrial permeabilization"

Phrase: "(56,"

Phrase: "60"

Phrase: ")"

Phrase: "and"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "caspase-independent apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1707313:Caspase-Independent Apoptosis [Molecular Function]
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(6062"

Phrase: ")."
Processing 00000000.tx.273: Here we demonstrate that C-peptide replacement prevents increased expression of caspase 12, indicative of endoplasmic reticulum dysfunction, nuclear stainability of 8-OHdG, reflecting oxidative stress-induced DNA damage, and nuclear staining of AIF. 

Phrase: "Here"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that C-peptide replacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "increased expression of caspase 12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "indicative of endoplasmic reticulum dysfunction,"

Phrase: "nuclear stainability of 8-OHdG,"

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "oxidative stress-induced DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   804   C0010957:Damage [Injury or Poisoning]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "nuclear staining of AIF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
Processing 00000000.tx.274: Therefore, C-peptide prevents mitochondrial and endoplasmic reticulum dysfunction and downstream oxidative stressinduced DNA damage. 

Phrase: "Therefore,"

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026237:Mitochondrial [Cell Component]
  1000   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "endoplasmic reticulum dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "and"

Phrase: "downstream oxidative stressinduced DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   804   C0010957:Damage [Injury or Poisoning]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1883709:Damage [Functional Concept]
Processing 00000000.tx.275: This is at odds with the lack of effects by C-peptide on peripheral nerve lipid peroxidation or antioxidant defense enzymes while correcting neurovascular deficits, thereby dissociating the latter from oxidative stress (63). 

Phrase: "This"

Phrase: "is at odds with the lack of effects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0332268:lack [Qualitative Concept]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "by C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "on peripheral nerve lipid peroxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023775:Lipid Peroxidation [Molecular Function]
   812   C0023779:Lipid [Lipid]
   812   C0178796:peroxidation [Phenomenon or Process]

Phrase: "or"

Phrase: "antioxidant defense enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "while"

Phrase: "correcting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349182:Correct [Qualitative Concept]

Phrase: "neurovascular deficits,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "thereby"

Phrase: "dissociating"

Phrase: "the latter from oxidative stress"

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.276: NGF can block ROS induction and stabilize mitochondrial membrane potential (48). 

Phrase: "NGF"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "can"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "ROS induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "and"

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.277: Here, C-peptide replacement prevented the decrease in endogenous NGF and NGFR-tryosine receptor kinase A expression. 

Phrase: "Here,"

Phrase: "C-peptide replacement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   734   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the decrease in endogenous NGF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "NGFR-tryosine receptor kinase A expression."
Meta Candidates (Total=25; Excluded=2; Pruned=0; Remaining=23)
   854   C0597360:receptor expression [Genetic Function]
   854   C0960756:factor A [Organic Chemical]
   849   C0254837:Receptor, Nerve Growth Factor [Amino Acid, Peptide, or Protein,Receptor]
   849   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]
   827   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   807   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   802   C0034837:Receptor, Neural [Cell Component]
   791   C0018270:'growth' NOS [Organism Function]
   791   C0027740:Nerve [Tissue]
   791   C0027757:NERVE [Tissue]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0185117:Expression [Therapeutic or Preventive Procedure]
   791   C0220844:growth [Physiologic Function]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C1280541:Nerve [Body Part, Organ, or Organ Component]
   791   C1521761:Factor [Functional Concept]
   791   C1621966:Growth [Organ or Tissue Function]
   791   C2827422:Factor [Conceptual Entity]
   791   C2911660:Growth [Activity]
   780   C0814002:Neural Growth [Cell Function,Organism Function]
   735 E C0599851:Neural [Functional Concept]
   720 E C0027769:nervy [Sign or Symptom]
Processing 00000000.tx.278: This is not unexpected, since insulin normalizes the expression of NGF (64) and is necessary for its binding to NGFR-tryosine receptor kinase A (65). 

Phrase: "This"

Phrase: "is"

Phrase: "not unexpected,"

Phrase: "since"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "normalizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "the expression of NGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(64"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "necessary for its binding"

Phrase: "to NGFR-tryosine receptor kinase A (65"
Meta Candidates (Total=24; Excluded=2; Pruned=0; Remaining=22)
   854   C0960756:factor A [Organic Chemical]
   849   C0254837:Receptor, Nerve Growth Factor [Amino Acid, Peptide, or Protein,Receptor]
   849   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]
   827   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   807   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   802   C0034837:Receptor, Neural [Cell Component]
   791   C0018270:'growth' NOS [Organism Function]
   791   C0027740:Nerve [Tissue]
   791   C0027757:NERVE [Tissue]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0220844:growth [Physiologic Function]
   791   C0450385:65 [Intellectual Product]
   791   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   791   C1280541:Nerve [Body Part, Organ, or Organ Component]
   791   C1521761:Factor [Functional Concept]
   791   C1621966:Growth [Organ or Tissue Function]
   791   C2827422:Factor [Conceptual Entity]
   791   C2911660:Growth [Activity]
   780   C0814002:Neural Growth [Cell Function,Organism Function]
   735 E C0599851:Neural [Functional Concept]
   720 E C0027769:nervy [Sign or Symptom]

Phrase: ")."
Processing 00000000.tx.279: Furthermore, the effect of C-peptide on NGFR p75 provides a further explanation, since activation of the Fas/TNF receptor family induces ROS via mitochondrial AIF release and lipid peroxidation (57,61,66,67). 

Phrase: "Furthermore,"

Phrase: "the effect of C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on NGFR p75"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0254837:Nerve Growth Factor Receptor p75 [Amino Acid, Peptide, or Protein,Receptor]
           Receptor, Nerve Growth Factor
   771   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]
   717   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a further explanation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "since"

Phrase: "activation of the Fas/TNF receptor family"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   810   C1519684:Tumor Necrosis Factor Activation [Physiologic Function]
   762   C1514758:Receptor Activation [Cell Function]
   742   C1879547:Activation [Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "ROS via mitochondrial AIF release"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0205332:Reactive [Qualitative Concept]
   742   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "lipid peroxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: "(57,"

Phrase: "61,"

Phrase: "66,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.280: The beneficial effects on the NGF system therefore contribute to the positive effects on oxidative stress. 

Phrase: "The beneficial effects on the NGF system therefore"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "contribute to the positive effects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0439178:% Positive [Quantitative Concept]
   760   C1280500:effects [Qualitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1880177:Contribute [Activity]
   760   C2825490:Positive [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.281: Apart from the role of the Fas/TNF pathway activation in exacerbating oxidative stress, it perturbs jun NH2-terminal kinase and p38, thereby fueling the apoptogenic effects caused by aberrations of the PI-3 kinase pathway (68). 

Phrase: "Apart from the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "of the Fas/TNF pathway activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1519684:Tumor Necrosis Factor Activation [Physiologic Function]
   799   C1879547:Activation [Activity]

Phrase: "in exacerbating oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "it"

Phrase: "perturbs"

Phrase: "jun NH2-terminal kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0248813:jun-NH2-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1334482:Jun kinase [Gene or Genome]
   902   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p38,"

Phrase: "thereby fueling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556991:fueling [Manufactured Object]

Phrase: "the apoptogenic effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "caused by aberrations of the PI-3 kinase pathway"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   762 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]
   742   C2348046:Phosphatidylinositol [Lipid]
   708   C0015127:cause [Functional Concept]
   708   C1524003:Cause [Conceptual Entity]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.282: PARP is activated by DNA strand breaks and plays a role in DNA repair and in apoptosis (69). 

Phrase: "PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: "is"

Phrase: "activated by DNA strand breaks"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   851   C0872150:DNA Strand Break [Cell or Molecular Dysfunction]
   806   C0301647:Strand breaks [Molecular Function]
   797   C1721104:DNA Breaks [Molecular Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1704972:Strand [Spatial Concept]
   760   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]
   726   C1881704:BREAK [Phenomenon or Process]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in DNA repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and in apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C1515981:And [Idea or Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.283: Apoptosis induces cleavage of the 113-kDa PARP into 89- and 24-kDa fragments. 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cleavage of the 113-kDa PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "into 89-"

Phrase: "and"

Phrase: "24-kDa fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.284: The presence of cleaved PARP is therefore an indication of apoptosis. 

Phrase: "The presence of cleaved PARP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "therefore"

Phrase: "an indication of apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392360:indication [Idea or Concept]
   770   C3146298:Indication [Functional Concept]
Processing 00000000.tx.285: PARP participates in caspase-independent apoptosis via the mitochondrial-derived AIF pathway (69). 

Phrase: "PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: "participates in caspase-independent apoptosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1707313:Caspase-Independent Apoptosis [Molecular Function]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0085862:Independent [Idea or Concept]
   760   C0162638:Apoptosis [Cell Function]
   760   C1299583:Independent [Finding]

Phrase: "via the mitochondrial-derived AIF pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1704259:Pathway [Molecular Function]
   799   C1705987:Pathway [Conceptual Entity]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.286: The prevention of 89-kDa PARP expression and nuclear presence of PARP in C-peptidereplaced BB/Wor rats suggest an effect on PARP-mediated caspase-independent apoptosis. 

Phrase: "The prevention of 89-kDa PARP expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C1706420:PREVENTION [Research Activity]
   748   C2700409:prevention [Qualitative Concept]

Phrase: "and"

Phrase: "nuclear presence of PARP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in C-peptidereplaced BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an effect on PARP-mediated caspase-independent apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.287: These findings were confirmed in human neuroblastoma cells exposed to high glucose, in which C-peptide together with insulin maximized the protective effect on the expression of cleaved PARP. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "were"

Phrase: "confirmed in human neuroblastoma cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   797   C0427861:Human cells [Laboratory or Test Result]
   790   C0815000:neuroblastoma cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0027819:Neuroblastoma [Neoplastic Process]
   760   C0086418:Human [Human]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0700095:neuroblastoma [Neoplastic Process]
   760   C0750484:Confirmed [Idea or Concept]
   760   C3282337:Cells [Cell]
   760   C3540583:Neuroblastoma [Intellectual Product]
   726 E C1269647:Cell [Cell]
   726 E C1456348:Confirm [Qualitative Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to high glucose,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C0860803:high glucose [Finding]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "in which C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "together with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "maximized"

Phrase: "the protective effect on the expression of cleaved PARP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.288: In summary, C-peptide replacement in type 1 diabetic rats prevents the progressive cognitive dysfunction by preventing apoptosis-induced neuronal loss in the hippocampus and potentially in other brain regions. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "C-peptide replacement in type 1 diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0035139:Replacement [Therapeutic or Preventive Procedure]
   744   C0559956:Replacement [Functional Concept]
   744   C1555302:Replacement [Idea or Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the progressive cognitive dysfunction by preventing apoptosis-induced neuronal loss"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   739   C0031847:dysfunction [Functional Concept]
   739   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "potentially in other brain regions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1273723:brain regions [Body Location or Region]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]
Processing 00000000.tx.289: Several apoptotic mechanisms are involved in this process. 

Phrase: "Several apoptotic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "involved in this process."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1314939:Involved [Functional Concept]
   770   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.290: C-peptide significantly prevented NGFR P75mediated apoptosis and oxidative stress-induced apoptotic activity, as well as PARP and AIF-related caspase-independent apoptotic stresses. 

Phrase: "C-peptide significantly prevented NGFR P75mediated apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "oxidative stress-induced apoptotic activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "as well as"

Phrase: "PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: "and"

Phrase: "AIF-related caspase-independent apoptotic stresses."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0038435:Stress [Finding]
   710 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.291: It had partial but significant effects on PI-3 kinase pathwayrelated apoptotic mechanisms. 

Phrase: "It"

Phrase: "had"

Phrase: "partial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728938:Partial [Quantitative Concept]
  1000   C1550516:partial [Idea or Concept]

Phrase: "but"

Phrase: "significant effects on PI-3 kinase pathwayrelated apoptotic mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.292: These effects were reflected in significant prevention of proapoptotic Bax and active caspase 3 expression. 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "reflected in significant prevention of proapoptotic Bax"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0237881:significant [Quantitative Concept]
   748   C0558058:reflected [Mental Process]
   748   C0750502:Significant [Idea or Concept]
   748   C0812198:BAX [Gene or Genome]
   748   C1546944:Significant [Qualitative Concept]
   748   C1706420:PREVENTION [Research Activity]
   748   C2700409:prevention [Qualitative Concept]

Phrase: "and"

Phrase: "active caspase 3 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.293: Therefore, the present data demonstrate that impaired insulinomimetic action by C-peptide plays a prominent role in primary diabetic encephalopathy. 

Phrase: "Therefore,"

Phrase: "the present data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that impaired insulinomimetic action by C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441472:Action [Functional Concept]
   748   C3266814:Action [Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a prominent role in primary diabetic encephalopathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.294: This is further supported by data from the age-, duration-, and hyperglycemia-matched type 2 diabetic BBZDR/Wor rat. 

Phrase: "This"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported by data"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1511726:Data [Idea or Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C3245479:data [Medical Device]
   756 E C0183683:Support [Medical Device]

Phrase: "from the age-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "duration-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "and"

Phrase: "hyperglycemia-matched type 2 diabetic BBZDR/Wor rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0034693:Rat, NOS [Mammal]
   793   C0034721:Rat [Mammal]
Processing 00000000.tx.295: This model shows normal C-peptide levels, significantly milder neuronal loss, and a spectrum of apoptotic activities (22) similar to those reported here in C-peptidereplaced type 1 BB/Wor rats. 

Phrase: "This model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "normal C-peptide levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   923   C0202100:c peptide levels [Laboratory Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "significantly milder neuronal loss,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1850496:Neuronal loss [Finding]
   825 E C0598940:neuron loss [Finding]
   812   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "a spectrum of apoptotic activities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883073:Spectrum [Quantitative Concept]
   760   C2827424:Spectrum [Conceptual Entity]

Phrase: "(22"

Phrase: ")"

Phrase: "similar to those reported here"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in C-peptidereplaced type 1 BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0034699:Rats, BB [Mammal]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]
Processing 00000000.tx.296: As this type 2 model becomes increasingly insulin and C-peptide deficient, it shows an acceleration in the development of diabetic polyneuropathy (37). 

Phrase: "As this type 2 model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3161035:Model [Intellectual Product]
   734   C0441730:Type 2 [Classification]

Phrase: "becomes"

Phrase: "increasingly insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "deficient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011155:Deficient [Functional Concept]
  1000   C1636779:% deficient [Quantitative Concept]

Phrase: "it"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an acceleration in the development of diabetic polyneuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0000894:Acceleration [Phenomenon or Process]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.297: One may speculate that a similar worsening of primary diabetic encephalopathy may occur as they become increasingly insulin and C-peptide deficient, potentially explaining the higher incidence of cognitive deficits in older patients with presumably longer duration of possibly insulin-deficient type 2 diabetes (9,10). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "may"

Phrase: "speculate"

Phrase: "that"

Phrase: "a similar worsening of primary diabetic encephalopathy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0332271:Worsening [Qualitative Concept]
   748   C1457868:Worsening [Qualitative Concept]
   748   C1546960:Worsening [Idea or Concept]
   714 E C1279889:worsen [Finding]

Phrase: "may"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "as"

Phrase: "they"

Phrase: "become"

Phrase: "increasingly insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "C-peptide deficient, potentially"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011155:Deficient [Functional Concept]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C1636779:% deficient [Quantitative Concept]

Phrase: "explaining"

Phrase: "the higher incidence of cognitive deficits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]

Phrase: "in older patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with presumably longer duration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0439591:Long duration [Qualitative Concept]
   827   C0449238:Duration [Temporal Concept]
   827   C2926735:Duration [Pharmacologic Substance]

Phrase: "of possibly insulin-deficient type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0011860:Type 2 Diabetes [Disease or Syndrome]
   839   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   839   C1320657:type diabetes [Finding]
   827   C0441730:Type 2 [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0011849:Diabetes [Disease or Syndrome]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.298: In conclusion, the present data show that impaired C-peptide activity in insulinopenic type 1 diabetes plays a prominent role in primary diabetic encephalopathy. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "the present data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that impaired C-peptide activity in insulinopenic type 1 diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a prominent role in primary diabetic encephalopathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.299: They suggest that proinsulin C-peptide replacement in type 1 diabetic patients is likely to have a protective effect on diabetes durationrelated cognitive deficits.  

Phrase: "They"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that proinsulin C-peptide replacement in type 1 diabetic patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0035139:Replacement [Therapeutic or Preventive Procedure]
   739   C0559956:Replacement [Functional Concept]
   739   C1555302:Replacement [Idea or Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "a protective effect on diabetes durationrelated cognitive deficits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.300: ACKNOWLEDGMENTS  These studies were supported in part by the Thomas Foundation, Bloomfield Hills, Michigan, and the Juvenile Diabetes Research Foundation, New York, New York. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by the Thomas Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "Bloomfield Hills,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442532:Hill [Spatial Concept]

Phrase: "Michigan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025939:Michigan [Geographic Area]

Phrase: "and"

Phrase: "the Juvenile Diabetes Research Foundation,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   819   C2986512:Research Base [Organization]
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]
Processing 00000000.tx.301: Address correspondence and reprint requests to Anders A.F. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0686900:request [Functional Concept]
  1000   C1272683:Request [Functional Concept]
  1000   C1522634:Request [Intellectual Product]

Phrase: "to Anders A.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.302: Sima, MD, PhD, Wayne State University, Department of Pathology, 540 E. 

Phrase: "Sima,"

Phrase: "MD,"

Phrase: "PhD,"

Phrase: "Wayne State University,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587487:Pathology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "540 E."
Processing 00000000.tx.303: Canfield Ave., Detroit, MI 48201. 

Phrase: "Canfield Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Detroit,"

Phrase: "MI 48201."
Processing 00000000.tx.304: E-mail: asima{at}med.wayne.edu Received for publication August 11, 2004 and accepted in revised form January 24, 2005 8-OHdG, 8-hydroxyl-2'-deoxyguanosine; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "asima{at}med.wayne.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication August 11,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2004"

Phrase: "and"

Phrase: "accepted in revised form January 24,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2005 8-OHdG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0050078:8-OHdG [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "8-hydroxyl-2'-deoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.305: AIF, apoptosis-inducing factor; 

Phrase: "AIF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "apoptosis-inducing factor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.306: NF-B, nuclear factor-B; 

Phrase: "NF-B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   901   C1824728:FACTOR B [Gene or Genome]

Phrase: "nuclear factor-B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   901   C1824728:FACTOR B [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.307: NGF, nerve growth factor; 

Phrase: "NGF,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "nerve growth factor"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: ";"
Processing 00000000.tx.308: NGFR, nerve growth factor receptor; 

Phrase: "NGFR,"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
  1000   C0254837:Receptor, Nerve Growth Factor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   875   C0034837:Receptor, Neural [Cell Component]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0814002:Neural Growth [Cell Function,Organism Function]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0027740:Nerve [Tissue]
   812   C0027757:NERVE [Tissue]
   812   C0220844:growth [Physiologic Function]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1280541:Nerve [Body Part, Organ, or Organ Component]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0599851:Neural [Functional Concept]
   741 E C0027769:nervy [Sign or Symptom]

Phrase: "nerve growth factor receptor"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
  1000   C0254837:Receptor, Nerve Growth Factor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1334879:NERVE GROWTH FACTOR RECEPTOR [Gene or Genome]
   923   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   875   C0034837:Receptor, Neural [Cell Component]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0814002:Neural Growth [Cell Function,Organism Function]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0027740:Nerve [Tissue]
   812   C0027757:NERVE [Tissue]
   812   C0220844:growth [Physiologic Function]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1280541:Nerve [Body Part, Organ, or Organ Component]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0599851:Neural [Functional Concept]
   741 E C0027769:nervy [Sign or Symptom]

Phrase: ";"
Processing 00000000.tx.309: PARP, poly(ADP-ribose) polymerase; 

Phrase: "PARP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: "poly(ADP-ribose) polymerase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           poly ADP polymerase
  1000   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]
   923   C0032403:Poly ADP Ribose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0001461:ADP Ribose [Biologically Active Substance,Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035549:Ribose [Carbohydrate]
   812   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0523452:ADP [Laboratory Procedure]
   812   C0747726:POLY [Conceptual Entity]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.310: PI-3, phosphatidyinositol-3; 

Phrase: "PI-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: "phosphatidyinositol-3"

Phrase: ";"
Processing 00000000.tx.311: ROS, reactive oxygen species; 

Phrase: "ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.312: TBS, tris-buffered saline; 

Phrase: "TBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.313: TNF, tumor necrosis factor; 

Phrase: "TNF,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: ";"
Processing 00000000.tx.314: TUNEL, terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Biessels GJ, Kapelle B, Bravenboer B, Erkeleus DW, Gispen WH: Cerebral function in diabetes mellitus. 

Phrase: "TUNEL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600528:TUNEL [Molecular Biology Research Technique]

Phrase: "terminal deoxynucleotidyl transferase"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0012881:Terminal Deoxynucleotidyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Terminal Transferase
           Deoxynucleotidyl Transferase
  1000   C0687124:Terminal deoxynucleotidyl transferase [Indicator, Reagent, or Diagnostic Aid]
  1000   C1333243:DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL [Gene or Genome]
           TERMINAL TRANSFERASE
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "(TdT"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0012881:Terminal Deoxynucleotidyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Terminal Transferase
           Deoxynucleotidyl Transferase
  1000   C0687124:Terminal deoxynucleotidyl transferase [Indicator, Reagent, or Diagnostic Aid]
  1000   C1333243:DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL [Gene or Genome]
           TERMINAL TRANSFERASE
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: ")-"

Phrase: "mediated dUTP nick-end labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1167624:Labeling [Mental Process]
   804   C1947902:Labeling [Manufactured Object]
   804   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Biessels GJ,"

Phrase: "Kapelle B,"

Phrase: "Bravenboer B,"

Phrase: "Erkeleus DW,"

Phrase: "Gispen WH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: ":"

Phrase: "Cerebral function in diabetes mellitus."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0234386:Cerebral function [Organ or Tissue Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.315: Diabetologia37 :643 650,1994[Medline] Sima AAF, Kamiya H, Li Z-G: Insulin, C-peptide, hyperglycemia and central nervous system complications in diabetes. 

Phrase: "Diabetologia37"

Phrase: ":"

Phrase: "643 650,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sima AAF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "Kamiya H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Li Z-G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "C-peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "central nervous system complications in diabetes."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   866   C0161815:Central nervous system complication [Pathologic Function]
   788   C0235029:NEUROLOGIC COMPLICATION [Pathologic Function]
   783   C0342257:Diabetes Complications [Pathologic Function]
   753   C0009566:Complications [Pathologic Function]
   753   C1171258:complications [Pathologic Function]
   719 E C2362589:Complication [Idea or Concept]
Processing 00000000.tx.316: Eur J Pharmacol490 :187 197,2004[Medline] Sima AAF: Diabetes underlies common neurological disorders. 

Phrase: "Eur J Pharmacol490"

Phrase: ":"

Phrase: "187 197,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "underlies"

Phrase: "common neurological disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027765:Neurological Disorders [Disease or Syndrome]
   827   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.317: Ann Neurol56 :459 461,2004[Medline] Ryan CM, Williams TM, Finegold DN, Orchard TJ: Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. 

Phrase: "Ann Neurol56"

Phrase: ":"

Phrase: "459 461,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ryan CM,"

Phrase: "Williams TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Finegold DN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333964:DN [Disease or Syndrome]
   861   C1707618:DN [Intellectual Product]

Phrase: "Orchard TJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: ":"

Phrase: "Cognitive dysfunction in adults"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "with type 1 (insulin-dependent) diabetes mellitus"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   913   C0011854:Diabetes Mellitus, Type 1 [Disease or Syndrome]
           Diabetes Mellitus, Insulin-Dependent
           Type 1 diabetes
           Insulin Dependent Diabetes
   876   C1320657:type diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0441729:Type 1 [Classification]
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0332307:Type [Qualitative Concept]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1547052:*Type [Quantitative Concept]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "of long duration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439591:Long duration [Qualitative Concept]
   861   C0449238:Duration [Temporal Concept]
   861   C2926735:Duration [Pharmacologic Substance]

Phrase: ":"

Phrase: "effects of recurrent hypoglycaemia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C2936720:Hypoglycemic Effects [Physiologic Function]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "other chronic complications."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.318: Diabetologia36 :329 334,1993[Medline] McCarthy AM, Lindgren S, Mengeking MA, Tsalikian E, Engvall JC: Effects of diabetes on learning in children. 

Phrase: "Diabetologia36"

Phrase: ":"

Phrase: "329 334,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McCarthy"

Phrase: "AM"

Phrase: ","

Phrase: "Lindgren S,"

Phrase: "Mengeking MA,"

Phrase: "Tsalikian E,"

Phrase: "Engvall JC"

Phrase: ":"

Phrase: "Effects of diabetes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "in children."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008059:Children [Age Group]
  1000   C0680063:Children [Family Group]
Processing 00000000.tx.319: Pediatrics109 :E91 E110,2002[Medline] Kramer L, Fasching P, Madl C, Schneider B, Damjancic P, Waldhusl W, Irsigler K, Grimm G: Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. 

Phrase: "Pediatrics109"

Phrase: ":"

Phrase: "E91 E110,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kramer L,"

Phrase: "Fasching P,"

Phrase: "Madl C,"

Phrase: "Schneider B,"

Phrase: "Damjancic P,"

Phrase: "Waldhusl W,"

Phrase: "Irsigler K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Grimm G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Previous episodes of hypoglycemic coma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0745153:Hypoglycemic episodes [Disease or Syndrome]
   790   C0332189:Episode of [Temporal Concept]
           Episodes

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with permanent cognitive brain dysfunction"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0262405:brain dysfunction [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0031847:dysfunction [Functional Concept]
   753   C0205355:Permanent [Temporal Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1516691:Cognitive [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in IDDM patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "on intensive insulin treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.320: Diabetes47 :1909 1914,1998[Abstract] Schoenle EJ, Schoenle D, Molinari L, Largo RH: Impaired intellectual development in children with type 1 diabetes: association with HbA(1c), age at diagnosis and sex. 

Phrase: "Diabetes47"

Phrase: ":"

Phrase: "1909 1914,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schoenle EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Schoenle D,"

Phrase: "Molinari L,"

Phrase: "Largo RH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: ":"

Phrase: "Impaired intellectual development in children"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678995:intellectual development [Mental Process]
   781   C0008071:Child Development [Organism Function]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "with type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "association with HbA(1c"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: ")"

Phrase: ","

Phrase: "age at diagnosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1828181:Age at diagnosis [Clinical Attribute]
   790   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]
Processing 00000000.tx.321: Diabetologia45 :108 114,2002[Medline] Strachan MW, Deary IJ, Ewing FM, Frier BM: Is type II diabetes associated with an increased risk of cognitive dysfunction? 

Phrase: "Diabetologia45"

Phrase: ":"

Phrase: "108 114,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strachan MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Deary IJ,"

Phrase: "Ewing FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Frier BM"

Phrase: ":"

Phrase: "Is"

Phrase: "type II diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type II [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "associated with an increased risk of cognitive dysfunction?"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   744   C0031847:dysfunction [Functional Concept]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0277785:Dysfunction, NOS [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1516691:Cognitive [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.322: A critical review of published studies. 

Phrase: "A critical review of published studies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0282443:Review [Intellectual Product]
   753   C1552617:Review [Idea or Concept]
Processing 00000000.tx.323: Diabetes Care20 :438 445,1997[Abstract] Ryan CM, Geckle M: Why is learning and memory dysfunction in type 2 diabetes limited to older adults? 

Phrase: "Diabetes Care20"

Phrase: ":"

Phrase: "438 445,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ryan CM,"

Phrase: "Geckle M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Why"

Phrase: "is"

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory dysfunction in type 2 diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0233794:Memory dysfunction [Mental or Behavioral Dysfunction]
   753   C0031847:dysfunction [Functional Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "limited to older adults?"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   816   C0001792:older adult [Population Group]
   770   C0001675:Adults [Age Group]
   770   C0439801:Limited [Functional Concept]
   770   C3542948:Limited [Intellectual Product]
   737   C0580836:Old [Temporal Concept]
   737 E C1549649:Limit [Idea or Concept]
   737 E C1706450:Adult [Human]
   737 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.324: Diabetes Metab Res Rev16 :308 315,2000[Medline] Reaven GM, Thompson LW, Nakum D, Haskins E: Relationship between hyperglycemia and cognitive function in older NIDDM patients. 

Phrase: "Diabetes Metab Res Rev16"

Phrase: ":"

Phrase: "308 315,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reaven GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Thompson LW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: "Nakum D,"

Phrase: "Haskins E"

Phrase: ":"

Phrase: "Relationship between hyperglycemia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439849:Relationship [Qualitative Concept]
   790   C1705630:Relationship [Idea or Concept]
   790   C1706279:Relationship [Idea or Concept]
   790   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "cognitive function in older NIDDM patients."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0392335:cognitive function [Mental Process]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1516691:Cognitive [Functional Concept]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.325: Diabetes Care13 :16 21,1990[Abstract] Sinclair AJ, Girling AJ, Bayer AJ: Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services: All Wales Research into Elderly (AWARE) study. 

Phrase: "Diabetes Care13"

Phrase: ":"

Phrase: "16 21,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sinclair AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Girling AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Bayer AJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: ":"

Phrase: "Cognitive dysfunction in older subjects"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "with diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "impact on diabetes self-management"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "and"

Phrase: "use of care services"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   881   C0814514:use of services [Individual Behavior]
           service use
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "All Wales"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043015:Wales [Geographic Area]
  1000   C1551837:Wales [Population Group]

Phrase: "Research into Elderly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001792:Elderly [Population Group]
   790   C0035168:research [Research Activity]
   790   C0242481:Research [Research Activity]
   790   C1999167:elderly [Population Group]

Phrase: "(AWARE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004448:Aware [Mental Process]

Phrase: ")"

Phrase: "study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.326: Diabetes Res Clin Pract50 :203 212,2000[Medline] Olt A, Stalk RP, von Harskamp F, Pols HAP, Hofman A, Breteler MMB: Diabetes mellitus and the risk of dementia: Rotterdam Study. 

Phrase: "Diabetes Res Clin Pract50"

Phrase: ":"

Phrase: "203 212,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Olt A,"

Phrase: "Stalk RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "von Harskamp F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Pols HAP,"

Phrase: "Hofman A,"

Phrase: "Breteler MMB"

Phrase: ":"

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "the risk of dementia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: ":"

Phrase: "Rotterdam Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.327: Neurology53 :1937 1942,1999[Abstract/Free FullText] Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Berenatt DA: Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. 

Phrase: "Neurology53"

Phrase: ":"

Phrase: "1937 1942,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Arvanitakis Z,"

Phrase: "Wilson RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Bienias JL,"

Phrase: "Evans DA,"

Phrase: "Berenatt DA"

Phrase: ":"

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "risk of Alzheimer disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1281905:disease risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "decline in cognitive function."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C0338656:Cognitive decline [Mental or Behavioral Dysfunction]
Processing 00000000.tx.328: Arch Neurol61 :661 666,2004[Abstract/Free FullText] Carro E, Torres-Aleman J: The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimers disease. 

Phrase: "Arch Neurol61"

Phrase: ":"

Phrase: "661 666,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Carro E,"

Phrase: "Torres-Aleman J"

Phrase: ":"

Phrase: "The role of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "insulin-like growth factor I in the molecular"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   869   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   833   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1753359:insulin-like growth factor [Molecular Function]
   770   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0021966:I- [Inorganic Chemical]
   744   C0220844:growth [Physiologic Function]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   739   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "cellular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the pathology of Alzheimers disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.329: Eur J Pharmacol490 :127 133,2004[Medline] Gasparini L, Xu H: Potential roles of insulin and IGF-1 in Alzheimers disease. 

Phrase: "Eur J Pharmacol490"

Phrase: ":"

Phrase: "127 133,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gasparini L,"

Phrase: "Xu H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Potential roles of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "IGF-1 in Alzheimers disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0021665:IGF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1425075:MALS-1 [Gene or Genome]
   760   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.330: Trends Neurosci26 :404 406,2003[Medline] Hong M, Lee VM-Y: Insulin and insulin-like growth factor 1 regulate tau phosphorylation in cultured human neurons. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci26"

Phrase: ":"

Phrase: "404 406,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hong M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee VM-Y"

Phrase: ":"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin-like growth factor 1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulate"

Phrase: "tau phosphorylation in cultured human neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.331: J Biol Chem272 :19547 19553,1997[Abstract/Free FullText] Flood JF, Mooradian AD, Morley JE: Characteristics of learning and memory in streptozotocin-induced diabetic mice. 

Phrase: "J Biol Chem272"

Phrase: ":"

Phrase: "19547 19553,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Flood JF,"

Phrase: "Mooradian AD,"

Phrase: "Morley JE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: ":"

Phrase: "Characteristics of learning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "memory in streptozotocin-induced diabetic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025260:Memory [Mental Process]
   753   C0700327:memory [Finding]
   753   C1706377:Memory [Manufactured Object]
Processing 00000000.tx.332: Diabetes39 :1391 1398,1990[Abstract] Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkeleus DW, Gispen NH: Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. 

Phrase: "Diabetes39"

Phrase: ":"

Phrase: "1391 1398,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Biessels GJ,"

Phrase: "Kamal A,"

Phrase: "Urban IJ,"

Phrase: "Spruijt BM,"

Phrase: "Erkeleus DW,"

Phrase: "Gispen NH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0268059:NH [Disease or Syndrome]

Phrase: ":"

Phrase: "Water maze learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0242996:Maze Learning [Mental Process]
   827   C0013621:learning [Educational Activity]
   827   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "hippocampal synaptic plasticity in streptozotocin-diabetic rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678558:Plasticity [Natural Phenomenon or Process]

Phrase: ":"

Phrase: "effects of insulin treatment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C1518681:Treatment Effect [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.333: Brain Res800 :125 135,1998[Medline] Kamal A, Biessels GJ, Duis SE, Gispen WH: Learning and hippocampal plasticity in streptozotocin-diabetic rats: interaction of diabetes and aging. 

Phrase: "Brain Res800"

Phrase: ":"

Phrase: "125 135,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kamal A,"

Phrase: "Biessels GJ,"

Phrase: "Duis SE,"

Phrase: "Gispen WH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: ":"

Phrase: "Learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "hippocampal plasticity in streptozotocin-diabetic rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678558:Plasticity [Natural Phenomenon or Process]

Phrase: ":"

Phrase: "interaction of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.334: Diabetologia43 :500 506,2000[Medline] Luesse HG, Schiefer J, Spruenken A, Puls C, Block F, Kosinski CM: Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntingtons disease: behavioral testing and impact of diabetes mellitus. 

Phrase: "Diabetologia43"

Phrase: ":"

Phrase: "500 506,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Luesse HG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025424:Hg [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C2347108:Hg+ [Element, Ion, or Isotope]
   861   C2347109:Hg++ [Element, Ion, or Isotope]
   861   C2348272:Hg [Element, Ion, or Isotope]

Phrase: "Schiefer J,"

Phrase: "Spruenken A,"

Phrase: "Puls C,"

Phrase: "Block F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Kosinski CM"

Phrase: ":"

Phrase: "Evaluation of R6/2 HD transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0220825:Evaluation [Functional Concept]
   748   C1261322:Evaluation [Health Care Activity]

Phrase: "for therapeutic studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1515402:Therapeutic Studies [Research Activity]
   861   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   861   C0302350:Therapeutic [Functional Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "in Huntingtons disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "behavioral testing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039593:Testing [Functional Concept]
   861   C0392366:testing [Intellectual Product]

Phrase: "and"

Phrase: "impact of diabetes mellitus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.335: Behav Brain Res126 :185 195,2001[Medline] Li Z, Zhang W, Grunberger G, Sima AAF: Hippocampal neuronal apoptosis in type 1 diabetes. 

Phrase: "Behav Brain Res126"

Phrase: ":"

Phrase: "185 195,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li Z,"

Phrase: "Zhang W,"

Phrase: "Grunberger G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "Hippocampal neuronal apoptosis in type 1 diabetes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0162638:Apoptosis [Cell Function]
   743   C1660771:neuron apoptosis [Cell Function]
   702 E C1836846:Apoptotic neurons [Finding]
Processing 00000000.tx.336: Brain Res946 :212 231,2002 Li ZG, Zhang W, Sima AAF: Different apoptotic pathways are involved in primary hippocampal apoptosis in type 1 and type 2 diabetes (Abstract). 

Phrase: "Brain Res946"

Phrase: ":"

Phrase: "212 231,"

Phrase: "2002 Li ZG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883598:zg [Quantitative Concept]

Phrase: "Zhang W,"

Phrase: "Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "Different apoptotic pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   848   C0162638:Apoptosis Pathway [Cell Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "involved in primary hippocampal apoptosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   760   C0162638:Apoptosis [Cell Function]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1314939:Involved [Functional Concept]

Phrase: "in type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type 1 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.337: Diabetes53 (Suppl. 2) :A212 ,2004 Biessels GJ, Kamal A, Ramakers GM, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH: Place learning and hippocampal synaptic plasticity in streptozotocin diabetic rats. 

Phrase: "Diabetes53"

Phrase: "(Suppl. 2"

Phrase: ")"

Phrase: ":"

Phrase: "A212 ,"

Phrase: "2004 Biessels GJ,"

Phrase: "Kamal A,"

Phrase: "Ramakers GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Urban IJ,"

Phrase: "Spruijt BM,"

Phrase: "Erkelens DW,"

Phrase: "Gispen WH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: ":"

Phrase: "Place learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013621:learning [Educational Activity]
   861   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "hippocampal synaptic plasticity in streptozotocin diabetic rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678558:Plasticity [Natural Phenomenon or Process]
Processing 00000000.tx.338: Diabetes45 :1259 1266,1996[Abstract] Gispen WH, Biessels GJ: Cognition and synaptic plasticity in diabetes mellitus. 

Phrase: "Diabetes45"

Phrase: ":"

Phrase: "1259 1266,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gispen WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Biessels GJ"

Phrase: ":"

Phrase: "Cognition"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "synaptic plasticity in diabetes mellitus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678558:Plasticity [Natural Phenomenon or Process]
Processing 00000000.tx.339: Trends Neurosci23 :542 549,2000[Medline] Biessels GJ, Cristino NA, Rutten GJ, Hamers FP, Erkelens DW, Gispen WH: Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats: course of development and effects of insulin treatment. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci23"

Phrase: ":"

Phrase: "542 549,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Biessels GJ,"

Phrase: "Cristino NA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1272460:{NA} [Qualitative Concept]

Phrase: "Rutten GJ,"

Phrase: "Hamers FP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1419068:FP [Gene or Genome]
   861   C1419906:FP [Gene or Genome]
   861   C3541238:Fp [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3541412:FP [Gene or Genome]

Phrase: "Erkelens DW,"

Phrase: "Gispen WH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: ":"

Phrase: "Neurophysiological changes in the central"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "peripheral nervous system of streptozotocin-diabetic rats"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   814   C0206417:Peripheral Nervous System [Body System]
   800 E C0869552:nervous peripheral system [Therapeutic or Preventive Procedure]
   788   C1882791:Rat Nervous System [Body Part, Organ, or Organ Component]
   778   C0027763:Nervous System [Body System]
   778   C0422837:NERVOUS SYSTEM [Finding]
   778   C1269560:Nervous system [Body System]
   755   C1882822:Rat Peripheral Nerve [Body Part, Organ, or Organ Component]
   748   C0027769:Nervous [Sign or Symptom]
   748   C0205100:Peripheral [Spatial Concept]
   748   C0449913:System [Functional Concept]
   748   C0599851:Nervous [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   723 E C0205494:Neurologic [Qualitative Concept]
   721   C0031119:Peripheral Nerves [Body Part, Organ, or Organ Component]
   721   C1280200:Peripheral nerve [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "course of development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750729:Course [Temporal Concept]

Phrase: "and"

Phrase: "effects of insulin treatment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C1518681:Treatment Effect [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.340: Brain122 :757 768,1999[Abstract/Free FullText] Morris R: Development of a water maze procedure for studying spatial learning in the rat. 

Phrase: "Brain122"

Phrase: ":"

Phrase: "757 768,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Morris R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Development of a water maze procedure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "for studying spatial learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0582587:spatial learning [Mental Process]
   827   C0013621:learning [Educational Activity]
   827   C0023185:Learning [Mental Process]

Phrase: "in the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.341: J Neurosci11 :47 60,1984 Grunberger G, Qiang X, Li Z-G, Mathews ST, Sbriessa D, Shisheva A, Sima AAF: Molecular basis for the insulinomimetic effects of C-peptide. 

Phrase: "J Neurosci11"

Phrase: ":"

Phrase: "47 60,"

Phrase: "1984 Grunberger G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Qiang X,"

Phrase: "Li Z-G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Mathews ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Sbriessa D,"

Phrase: "Shisheva A,"

Phrase: "Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "Molecular basis for the insulinomimetic effects of C-peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1853126:MOLECULAR BASIS [Idea or Concept]
   742   C1527178:Basis [Functional Concept]
   742   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.342: Diabetologia44 :1247 1257,2001[Medline] Sima AAF, Zhang W, Li Z-G, Murakawa Y, Pierson CR: Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide. 

Phrase: "Diabetologia44"

Phrase: ":"

Phrase: "1247 1257,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sima AAF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "Zhang W,"

Phrase: "Li Z-G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Murakawa Y,"

Phrase: "Pierson CR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: ":"

Phrase: "Molecular alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "underlie"

Phrase: "nodal"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0443268:Nodal [Spatial Concept]
  1000   C1417752:NODAL [Gene or Genome]
   928 E C0449725:Nodality [Spatial Concept]
   928 E C0746922:Node [Body Part, Organ, or Organ Component]
   928 E C1706163:Node [Conceptual Entity]
   928 E C2697524:Node [Conceptual Entity]
   928 E C2700445:Node [Plant]

Phrase: "and"

Phrase: "paranodal degeneration in type 1 diabetic neuropathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011164:Degeneration [Pathologic Function]
   748   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "are"

Phrase: "prevented by C-peptide."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   819 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   737   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.343: Diabetes53 :1556 1563,2004[Abstract/Free FullText] Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson B-L, Rigler R, Jrnvall H: Role of C-peptide in human physiology (Review). 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "1556 1563,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wahren J,"

Phrase: "Ekberg K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Johansson J,"

Phrase: "Henriksson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pramanik A,"

Phrase: "Johansson B-L,"

Phrase: "Rigler R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Jrnvall H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Role of C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in human physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]

Phrase: "(Review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.344: Am J Physiol Endocrinol Metab278 :E759 E768,2000[Abstract/Free FullText] Zhang W, Yorek M, Pierson CR, Murakawa Y, Breidenbach A, Sima AAF: Human C-peptide dose dependently prevents early neuropathy in the BB/Wor rat. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab278"

Phrase: ":"

Phrase: "E759 E768,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang W,"

Phrase: "Yorek M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pierson CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Murakawa Y,"

Phrase: "Breidenbach A,"

Phrase: "Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "Human C-peptide dose dependently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "early neuropathy in the BB/Wor rat."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442874:Neuropathy [Disease or Syndrome]
Processing 00000000.tx.345: Internatl J Exp Diabetes Res2 :187 194,2001 Sima AAF: C-peptide and diabetic neuropathy (Review). 

Phrase: "Internatl J Exp Diabetes Res2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0893610:ReS2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: ":"

Phrase: "187 194,"

Phrase: "2001 Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "diabetic neuropathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011882:Diabetic neuropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
   861   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "(Review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.346: Expert Opin Investig Drugs12 :1471 1488,2003[Medline] Kitamura T, Kimura K, Makondo K, Furuya DT, Suzuki M, Yoshida T, Saito M: Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. 

Phrase: "Expert Opin Investig Drugs12"

Phrase: ":"

Phrase: "1471 1488,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kitamura T,"

Phrase: "Kimura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Makondo K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Furuya DT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3539739:DT [Gene or Genome]
   861   C3542920:DT [Idea or Concept]

Phrase: "Suzuki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yoshida T,"

Phrase: "Saito M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Proinsulin C-peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006558:Proinsulin C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           C-Peptide
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0033268:production [Occupational Activity]

Phrase: "of endothelial nitric oxide synthase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in aortic endothelial cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0225336:Endothelial Cells [Cell]
   827   C0003483:Aortic [Body Part, Organ, or Organ Component]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "of Wistar rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034716:Rats, Wistar [Mammal]
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C2700262:Wistar [Mammal]
Processing 00000000.tx.347: Diabetologia46 :1698 1705,2003[Medline] Li H, Xu L, Dunbar JC, Dhabuwala CB, Sima AAF: Effects of C-peptide on expression of endothelial NOS (eNOS) and inducible NOS (iNOS) in human cavernosal smooth muscle cell. 

Phrase: "Diabetologia46"

Phrase: ":"

Phrase: "1698 1705,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Xu L,"

Phrase: "Dunbar JC,"

Phrase: "Dhabuwala CB,"

Phrase: "Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "Effects of C-peptide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of endothelial NOS (eNOS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014257:Endothelial [Tissue]
   861   C1518425:{NOS} [Qualitative Concept]

Phrase: "and"

Phrase: "inducible NOS (iNOS) in human cavernosal smooth muscle cell."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1518425:{NOS} [Qualitative Concept]
Processing 00000000.tx.348: J Urol64 :622 627,2004 Li Z-G, Zhang W, Sima AAF: C-peptide enhances insulin-mediated cell growth and protection against high glucose induced apoptosis in SH-SY5Y cells. 

Phrase: "J Urol64"

Phrase: ":"

Phrase: "622 627,"

Phrase: "2004 Li Z-G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "Zhang W,"

Phrase: "Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "insulin-mediated cell growth"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007595:Cell Growth [Cell Function]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   708   C0030281:Insulin Cell [Cell]

Phrase: "and"

Phrase: "protection against high glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "apoptosis in SH-SY5Y cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.349: Diabetes Metab Res Rev19 :375 385,2003[Medline] Sima AAF: New insights into the metabolic and molecular basis for diabetic neuropathy. 

Phrase: "Diabetes Metab Res Rev19"

Phrase: ":"

Phrase: "375 385,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "New insights into the metabolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:insights [Mental Process]

Phrase: "and"

Phrase: "molecular basis for diabetic neuropathy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1853126:MOLECULAR BASIS [Idea or Concept]
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.350: Cell Mol Life Sci60 :2445 2464,2003[Medline] Jensen ME, Messina EJ: C-peptide induces a concentration-dependent dilatation of skeletal muscle arterioles only in the presence of insulin. 

Phrase: "Cell Mol Life Sci60"

Phrase: ":"

Phrase: "2445 2464,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jensen"

Phrase: "ME,"

Phrase: "Messina EJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: ":"

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a concentration-dependent dilatation of skeletal muscle arterioles only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0012356:Dilatation [Therapeutic or Preventive Procedure]
   742   C0012359:Dilatation [Pathologic Function]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.351: Am J Physiol276 :H1223 H1228,1999[Medline] Sima AAF, Kamiya H: Insulin, C-peptide and diabetic neuropathy. 

Phrase: "Am"

Phrase: "J Physiol276"

Phrase: ":"

Phrase: "H1223 H1228,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sima AAF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "Kamiya H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "diabetic neuropathy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011882:Diabetic neuropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
   861   C0442874:Neuropathy [Disease or Syndrome]
Processing 00000000.tx.352: Science Med10 :308 319,2004 Sima AAF, Zhang W, Xu G, Sugimoto K, Guberski DL, Yorek MA: A comparison of diabetic polyneuropathy in type-2 diabetic BBZDR/Wor rat and in type 1 diabetic BB/Wor rat. 

Phrase: "Science Med10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1825959:MED10 [Gene or Genome]

Phrase: ":"

Phrase: "308 319,"

Phrase: "2004 Sima AAF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "Zhang W,"

Phrase: "Xu G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Sugimoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Guberski DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Yorek MA"

Phrase: ":"

Phrase: "A comparison of diabetic polyneuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "in type-2 diabetic BBZDR/Wor rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:Rat, NOS [Mammal]
   799   C0034721:Rat [Mammal]

Phrase: "and in type 1 diabetic BB/Wor rat."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0441729:Type 1 [Classification]
   767   C0034699:Rat, BB [Mammal]
   767   C1514732:Rat-1 [Cell]
   744   C0004739:BB [Geographic Area]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0241863:DIABETIC [Finding]
   744   C0332297:BB [Spatial Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C1515981:And [Idea or Concept]
   744   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.353: Diabetologia43 :786 793,2000[Medline] Sima AAF, Zhang W-X, Sugimoto K, Henry D, Li Z-G, Wahren J, Grunberger G: C-peptide prevents and improves chronic type 1 diabetic neuropathy in the BB/Wor rat. 

Phrase: "Diabetologia43"

Phrase: ":"

Phrase: "786 793,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sima AAF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "Zhang W-X,"

Phrase: "Sugimoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Henry D,"

Phrase: "Li Z-G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Wahren J,"

Phrase: "Grunberger G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "and"

Phrase: "improves"

Phrase: "chronic type 1 diabetic neuropathy in the BB/Wor rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011882:Diabetic neuropathy [Disease or Syndrome]
   739   C0442874:Neuropathy [Disease or Syndrome]
Processing 00000000.tx.354: Diabetologia44 :889 897,2001[Medline] Praxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. 

Phrase: "Diabetologia44"

Phrase: ":"

Phrase: "889 897,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Praxinos G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Watson C"

Phrase: ":"

Phrase: "The Rat Brain in Stereotaxic Coordinates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.355: Sydney, Academic Press, 1982 Majdan M, Wash GS, Aloyg R, Miller FD: TrkA mediates developmental sympathetic neuron survival in vivo by silencing an ongoing p75NTR-mediated death signal. 

Phrase: "Sydney,"

Phrase: "Academic Press,"

Phrase: "1982 Majdan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Wash GS,"

Phrase: "Aloyg R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Miller FD"

Phrase: ":"

Phrase: "TrkA"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "developmental sympathetic neuron survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1819944:neuron survival [Cell Function]
   812   C0038952:Survival [Activity]
   812   C0220921:survival [Functional Concept]

Phrase: "in vivo by silencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "an ongoing p75NTR-mediated death signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.356: J Cell Biol155 :1275 1285,2001[Abstract/Free FullText] Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M: Role of poly (ADP-ribose) polymerase (PARP) cleavage in apoptosis: caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. 

Phrase: "J Cell Biol155"

Phrase: ":"

Phrase: "1275 1285,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Boulares AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Yakovlev AG,"

Phrase: "Ivanova V,"

Phrase: "Stoica BA,"

Phrase: "Wang G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Iyer S,"

Phrase: "Smulson M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Role of poly (ADP-ribose) polymerase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   716   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]

Phrase: "(PARP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032405:PARP [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1538577:PARP [Gene or Genome]
  1000   C1709384:PARP [Gene or Genome]

Phrase: ")"

Phrase: "cleavage in apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: ":"

Phrase: "caspase 3-resistant PARP mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "rates of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0871208:Rate [Activity]
   756   C1521828:Rate [Quantitative Concept]

Phrase: "in transfected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.357: J Biol Chem274 :22932 22940,1999[Abstract/Free FullText] Schmeichel JD, Schmelzer JD, Low PA: Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. 

Phrase: "J Biol Chem274"

Phrase: ":"

Phrase: "22932 22940,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schmeichel JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Schmelzer JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Low PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: ":"

Phrase: "Oxidative injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "and"

Phrase: "apoptosis of dorsal root ganglion neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   820   C1660771:Apoptosis of neurons [Cell Function]
           neuron apoptosis
   753   C0162638:Apoptosis [Cell Function]
   748 E C1836846:Apoptotic neurons [Finding]

Phrase: "in chronic experimental diabetic neuropathy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011882:Diabetic neuropathy [Disease or Syndrome]
   812   C0241863:DIABETIC [Finding]
   812   C0442874:Neuropathy [Disease or Syndrome]
Processing 00000000.tx.358: Diabetes52 :165 171,2003[Abstract/Free FullText] Eijirik DL, Darville MJ: -Cell apoptosis and defense mechanisms: lessons from type 1 diabetes. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "165 171,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eijirik DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Darville MJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: ": -"

Phrase: "Cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "defense mechanisms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011142:Defense Mechanisms [Mental Process]
   861   C0441712:Mechanisms [Functional Concept]
   861   C1880266:Defense [Conceptual Entity]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "lessons from type 1 diabetes."
Processing 00000000.tx.359: Diabetes50 (Suppl. 1) :S64 S69,2001[Medline] Mandrup-Poulsen T: -Cell apoptosis, stimuli and signaling. 

Phrase: "Diabetes50"

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "S64 S69,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mandrup-Poulsen T"

Phrase: ": -"

Phrase: "Cell apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimuli [Phenomenon or Process]

Phrase: "and"

Phrase: "signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
Processing 00000000.tx.360: Diabetes50 (Suppl 1) :S58 S63,2001[Medline] Asnagi V, Gerhardinger C, Hoehu T, Adeboje A, Lorenzi M: A role for the polyol pathway in early neuroretinal apoptosis and glial changes induced by diabetes in the rat. 

Phrase: "Diabetes50"

Phrase: "(Suppl 1"

Phrase: ")"

Phrase: ":"

Phrase: "S58 S63,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Asnagi V,"

Phrase: "Gerhardinger C,"

Phrase: "Hoehu T,"

Phrase: "Adeboje A,"

Phrase: "Lorenzi M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "A role for the polyol pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in early neuroretinal apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "glial changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "induced by diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0205263:Induced [Functional Concept]

Phrase: "in the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.361: Diabetes52 :506 511,2003[Abstract/Free FullText] Srinivasan S, Stevens M, Wiley JW: Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "506 511,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Srinivasan S,"

Phrase: "Stevens M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wiley JW"

Phrase: ":"

Phrase: "Diabetic peripheral neuropathy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0740447:Diabetic peripheral neuropathy [Disease or Syndrome]
   913   C0011882:Diabetic neuropathy [Disease or Syndrome]
   901   C0031117:Peripheral Neuropathy [Disease or Syndrome]
   827   C0205100:Peripheral [Spatial Concept]
   827   C0241863:DIABETIC [Finding]
   827   C0442874:Neuropathy [Disease or Syndrome]

Phrase: ":"

Phrase: "evidence for apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "associated mitochondrial dysfunction."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.362: Diabetes49 :1932 1938,2000[Abstract] Vincent AM, Brownlee M, Russel JW: Oxidative stress and programmed cell death in diabetic neuropathy. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "1932 1938,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Vincent"

Phrase: "AM"

Phrase: ","

Phrase: "Brownlee M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Russel JW"

Phrase: ":"

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "programmed cell death in diabetic neuropathy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0162638:Programmed Cell Death [Cell Function]
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.363: Ann N Y Acad Sci959 :368 383,2002[Abstract/Free FullText] Cheng C, Zochodne DW: Sensory neurons with activated caspase-3 survive long term experimental diabetes. 

Phrase: "Ann N Y Acad Sci959"

Phrase: ":"

Phrase: "368 383,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cheng C,"

Phrase: "Zochodne DW"

Phrase: ":"

Phrase: "Sensory neurons with activated caspase-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0027883:sensory neurons [Cell]
   790   C0034837:Neurons, Sensory [Cell Component]
   753   C0027882:Neurons [Cell]
   753   C0445254:Sensory [Qualitative Concept]

Phrase: "survive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "long term experimental diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.364: Diabetes52 :2361 2371,2003 Lee-Kwon W, Park D, Baskar PV, Kole S, Bernier M: Antiapoptotic signaling by the insulin receptor in Chinese hamster ovary cells. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "2361 2371,"

Phrase: "2003 Lee-Kwon W,"

Phrase: "Park D,"

Phrase: "Baskar PV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032463:PV [Neoplastic Process]

Phrase: "Kole S,"

Phrase: "Bernier M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Antiapoptotic signaling by the insulin receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1514762:Receptor Signaling [Molecular Function]
   753   C0037083:Signaling [Cell Function]
   753   C3537152:signaling [Biologic Function]

Phrase: "in Chinese hamster ovary cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   966   C0085080:Chinese Hamster Ovary Cell [Cell]
   861   C0018555:Chinese Hamster [Mammal]
   812   C0007634:Cells [Cell]
   812   C0008120:chinese [Language]
   812   C0018557:Hamster [Mammal]
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0152035:Chinese [Population Group]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.365: Biochemistry37 :15747 15757,1998[Medline] Aggarwal BB: Apoptosis and nuclear factor-kappa B: a tale of association and dissociation. 

Phrase: "Biochemistry37"

Phrase: ":"

Phrase: "15747 15757,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Aggarwal BB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: ":"

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "nuclear factor-kappa B"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0079904:Nuclear Factor kappa B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   875   C1824728:FACTOR B [Gene or Genome]
   812   C0439099:Kappa [Intellectual Product]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: ":"

Phrase: "a tale of association"

Phrase: "and"

Phrase: "dissociation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086168:Dissociation [Mental or Behavioral Dysfunction]
Processing 00000000.tx.366: Biochem Pharmacol60 :1033 1039,2000[Medline] Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, Merville MP: Nuclear factor-kappa B, cancer, and apoptosis. 

Phrase: "Biochem Pharmacol60"

Phrase: ":"

Phrase: "1033 1039,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bours V,"

Phrase: "Bentires-Alj M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Hellin AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Viatour P,"

Phrase: "Robe P,"

Phrase: "Delhalle S,"

Phrase: "Benoit V,"

Phrase: "Merville MP"

Phrase: ":"

Phrase: "Nuclear factor-kappa B,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0079904:Nuclear Factor kappa B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   875   C1824728:FACTOR B [Gene or Genome]
   812   C0439099:Kappa [Intellectual Product]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.367: Biochem Pharmacol60 :1085 1089,2000[Medline] LeRoith D: The insulin-like growth factor system. 

Phrase: "Biochem Pharmacol60"

Phrase: ":"

Phrase: "1085 1089,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] LeRoith D"

Phrase: ":"

Phrase: "The insulin-like growth factor system."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   771   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1753359:insulin-like growth factor [Molecular Function]
   733 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.368: Exp Diabetes Res4 :205 212,2003 Sima AAF, Ristic H, Merry A, Kamijo M, Lattimer SA, Stevens MJ, Greene DA: The primary preventional and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the BB/W rat. 

Phrase: "Exp Diabetes Res4"

Phrase: ":"

Phrase: "205 212,"

Phrase: "2003 Sima AAF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "Ristic H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Merry A,"

Phrase: "Kamijo M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lattimer SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Stevens MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Greene DA"

Phrase: ":"

Phrase: "The primary preventional"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   964   C0033144:Primary Prevention [Therapeutic or Preventive Procedure]
   789   C0199176:Prevention [Therapeutic or Preventive Procedure]
   789   C1706420:PREVENTION [Research Activity]
   789   C2700409:prevention [Qualitative Concept]

Phrase: "and"

Phrase: "secondary interventionary effects of acetyl-L-carnitine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on diabetic neuropathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011882:Diabetic neuropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
   861   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "in the BB/W rat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0034699:Rat, BB [Mammal]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
Processing 00000000.tx.369: J Clin Invest97 :1900 1907,1996[Abstract/Free FullText] Brownlee M, Sakamoto K: Biochemistry and molecular biology of diabetic complications. 

Phrase: "J Clin Invest97"

Phrase: ":"

Phrase: "1900 1907,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brownlee M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sakamoto K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "molecular biology of diabetic complications."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   760   C0005532:Biology [Biomedical Occupation or Discipline]
   760   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.370: In Type 1 Diabetes: Etiology and Treatment. 

Phrase: "In Type 1 Diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "Etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "Treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.371: Sperling MA, Ed. 

Phrase: "Sperling MA,"

Phrase: "Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]
Processing 00000000.tx.372: Totowa, NJ, Humana Press, 2003, p. 

Phrase: "Totowa,"

Phrase: "NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: "Humana Press,"

Phrase: "2003,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.373: 375392 Suzuki Y, Ono Y, Hirabayashi Y: Rapid and specific reactive oxygen species generation via NADP oxidative activation during Fas-mediated apoptosis. 

Phrase: "375392 Suzuki Y,"

Phrase: "Ono Y,"

Phrase: "Hirabayashi Y"

Phrase: ":"

Phrase: "Rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "specific reactive oxygen species generation via NADP oxidative activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0079411:Generation [Temporal Concept]
   742   C3146294:Generation [Activity]

Phrase: "during Fas-mediated apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.374: FEBS Lett425 :209 212,1998[Medline] Lee MW, Park SC, Kim JH, Kim IK, Hau KS, Kim KY, Lee WB, Jung YK, Kim SS: The involvement of oxidative stress in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in HeLa cells. 

Phrase: "FEBS Lett425"

Phrase: ":"

Phrase: "209 212,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Park SC,"

Phrase: "Kim JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Kim IK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416378:IK [Gene or Genome]

Phrase: "Hau KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Kim KY,"

Phrase: "Lee WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582525:Wb [Quantitative Concept]

Phrase: "Jung YK,"

Phrase: "Kim SS"

Phrase: ":"

Phrase: "The involvement of oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "(TNF)-related apoptosis-inducing ligand"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
  1000   C0385242:tumor necrosis factor-related apoptosis-inducing ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   845   C1323304:tumor necrosis factor [Molecular Function]
   845   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0333516:Tumor necrosis [Neoplastic Process]
   795   C0023688:Ligand [Chemical]
   795   C0027540:Necrosis [Organ or Tissue Function]
   795   C0027651:Tumor [Neoplastic Process]
   795   C0162638:Apoptosis [Cell Function]
   795   C0205263:Inducing [Functional Concept]
   795   C0439849:Related [Qualitative Concept]
   795   C0445223:Related [Finding]
   795   C1334928:Necrosis [Finding]
   795   C1521761:Factor [Functional Concept]
   795   C1578706:Tumor [Intellectual Product]
   795   C2827422:Factor [Conceptual Entity]
   795   C3273930:Tumor [Finding]
   762 E C0163712:Relate [Organic Chemical]
   724 E C0080103:Relation [Family Group]
   724 E C0869014:Relations [Social Behavior]
   724 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(TRAIL)-induced apoptosis in HeLa cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.375: Cancer Lett182 :75 82,2002[Medline] Andrieu-Abachi N, Gauaze V, Salvayre R, Levade T: Ceramide in apoptosis signaling: relationship with oxidative stress. 

Phrase: "Cancer Lett182"

Phrase: ":"

Phrase: "75 82,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Andrieu-Abachi N,"

Phrase: "Gauaze V,"

Phrase: "Salvayre R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Levade T"

Phrase: ":"

Phrase: "Ceramide in apoptosis signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: ":"

Phrase: "relationship with oxidative stress."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.376: Free Radic Biol Med31 :717 728,2001[Medline] Ishikawa Y, Satoh T, Enokido Y, Nishio C, Ikeuchi T, Hatanaka H: Generation of reactive oxygen species, release of L-glutamate and activation of caspases are required for oxygen-induced apoptosis of embryonic hippocampal neurons in culture. 

Phrase: "Free Radic Biol Med31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1537683:MED31 [Gene or Genome]

Phrase: ":"

Phrase: "717 728,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ishikawa Y,"

Phrase: "Satoh T,"

Phrase: "Enokido Y,"

Phrase: "Nishio C,"

Phrase: "Ikeuchi T,"

Phrase: "Hatanaka H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Generation of reactive oxygen species,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "release of L-glutamate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activation of caspases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C1159825:Caspase Activation [Molecular Function]
   790   C1879547:Activation [Activity]

Phrase: "are"

Phrase: "required for oxygen-induced apoptosis of embryonic hippocampal neurons"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   784   C1660771:Apoptosis of neurons [Cell Function]
           neuron apoptosis
   742   C0013935:Embryonic [Embryonic Structure]
   742   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   742   C0027882:Neurons [Cell]
   742   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0162638:Apoptosis [Cell Function]
   742   C0205263:Induced [Functional Concept]
   742   C1514873:Required [Functional Concept]
   726 E C1836846:Apoptotic neurons [Finding]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.377: Brain Res824 :71 80,1999[Medline] Cand C, Cohen I, Dangas E, Ravagnan L, Larochette N, Zamzami N, Kroemer G: Apoptosis-inducing factor (AIF): a novel caspase independent death effector released from mitochondria. 

Phrase: "Brain Res824"

Phrase: ":"

Phrase: "71 80,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cand C,"

Phrase: "Cohen I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Dangas E,"

Phrase: "Ravagnan L,"

Phrase: "Larochette N,"

Phrase: "Zamzami N,"

Phrase: "Kroemer G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Apoptosis-inducing factor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(AIF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: ":"

Phrase: "a novel caspase independent death effector"

Phrase: "released from mitochondria."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0026237:Mitochondria [Cell Component]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.378: Biochimie84 :215 222,2002[Medline] Cand C, Vahsen N, Garrido C, Kroemer G: Apoptosis-inducing factor (AIF): caspase independent after all. 

Phrase: "Biochimie84"

Phrase: ":"

Phrase: "215 222,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cand C,"

Phrase: "Vahsen N,"

Phrase: "Garrido C,"

Phrase: "Kroemer G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Apoptosis-inducing factor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(AIF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: ":"

Phrase: "caspase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "independent after all."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085862:Independent [Idea or Concept]
   790   C1299583:Independent [Finding]
Processing 00000000.tx.379: Cell Death Diff11 :591 595,2004[Medline] Penninger JM, Kroemer G: Mitochondria, AIF and caspases: rivaling for cell death execution. 

Phrase: "Cell Death Diff11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0007587:Cell Death [Cell Function]

Phrase: ":"

Phrase: "591 595,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Penninger JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Kroemer G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "AIF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "caspases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "rivaling for cell death execution."
Processing 00000000.tx.380: Nat Cell Biol5 :97 99,2003[Medline] Stevens MJ, Zhang W, Li F, Sima AAF: C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. 

Phrase: "Nat Cell Biol5"

Phrase: ":"

Phrase: "97 99,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stevens MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Zhang W,"

Phrase: "Li F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "C-peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "corrects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "endoneurial blood flow"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   901   C0232338:Blood flow [Organism Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0229664:Blood [Body Substance]
   827   C0806140:Flow [Natural Phenomenon or Process]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "but"

Phrase: "not oxidative stress in type 1 BB/Wor rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   742   C0038435:Stress [Finding]
   742   C0311404:Oxidative [Functional Concept]
Processing 00000000.tx.381: Am J Physiol287 :E497 E505,2004 Pierson CR, Zhang W, Sima AAF: Proinsulin C-peptide replacement in type 1 diabetic BB/Wor rats prevents deficits in nerve fiber regeneration. 

Phrase: "Am"

Phrase: "J Physiol287"

Phrase: ":"

Phrase: "E497 E505,"

Phrase: "2004 Pierson CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0201975:Cr [Laboratory Procedure]
   827   C3539604:CR [Gene or Genome]

Phrase: "Zhang W,"

Phrase: "Sima AAF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: ":"

Phrase: "Proinsulin C-peptide replacement in type 1 diabetic BB/Wor rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0035139:Replacement [Therapeutic or Preventive Procedure]
   738   C0559956:Replacement [Functional Concept]
   738   C1555302:Replacement [Idea or Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "deficits in nerve fiber regeneration."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.382: J Neuropath Exp Neurology62 :765 779,2003 Recio-Pinto E, Lang FF, Ishii DN: Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells. 

Phrase: "J Neuropath Exp Neurology62"

Phrase: ":"

Phrase: "765 779,"

Phrase: "2003 Recio-Pinto E,"

Phrase: "Lang FF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539653:FF [Idea or Concept]

Phrase: "Ishii DN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1333964:DN [Disease or Syndrome]
   861   C1707618:DN [Intellectual Product]

Phrase: ":"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin-like growth factor II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "permit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "nerve growth factor binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1522949:nerve growth factor binding [Molecular Function]
   923   C1149299:Growth Factor Binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   756   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "the neurite formation response in cultured human neuroblastoma cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]
Processing 00000000.tx.383: Proc Natl Acad Sci U S A81 :2562 2566,1984[Abstract] Barrett GL: The p75 neurotrophin receptor and neuronal apoptosis. 

Phrase: "Proc Natl Acad Sci U S A81"

Phrase: ":"

Phrase: "2562 2566,"

Phrase: "1984"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Barrett GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "The p75 neurotrophin receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0254837:p75 Neurotrophin Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0132298:Neurotrophin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1323315:neurotrophin [Molecular Function]
   827   C1332408:neurotrophin [Gene or Genome]

Phrase: "and"

Phrase: "neuronal apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   964   C1660771:neuron apoptosis [Cell Function]
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.384: Prog Neurobiol61 :205 209,2000[Medline] Hirata H, Hibasami H, Yoshida T, Ogawa M, Matsumoto M, Morita A, Uchida A: Nerve growth factor signaling of p75 induces differentiation and ceramide-mediated apoptosis in Schwann cells cultured from degenerative nerves. 

Phrase: "Prog Neurobiol61"

Phrase: ":"

Phrase: "205 209,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hirata H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hibasami H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yoshida T,"

Phrase: "Ogawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Matsumoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Morita A,"

Phrase: "Uchida A"

Phrase: ":"

Phrase: "Nerve growth factor signaling of p75"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037083:Signaling [Cell Function]
   753   C3537152:signaling [Biologic Function]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "ceramide-mediated apoptosis in Schwann cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162638:Apoptosis [Cell Function]

Phrase: "cultured from degenerative nerves."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0011164:Degenerative [Pathologic Function]
   770   C0027740:Nerves [Tissue]
   770   C1880269:Degenerative [Functional Concept]
   737   C0010453:Culture [Idea or Concept]
   737 E C0027757:NERVE [Tissue]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   737   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.385: Glia36 :245 258,2001[Medline] Yang X, Khosravi-Far R, Chang HY, Baltimore D: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. 

Phrase: "Glia36"

Phrase: ":"

Phrase: "245 258,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yang X,"

Phrase: "Khosravi-Far R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Chang HY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: "Baltimore D"

Phrase: ":"

Phrase: "Daxx,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0541030:DAXX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333203:DAXX [Gene or Genome]

Phrase: "a novel Fas-binding protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2611764:FAS binding [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.386: Cell89 :1067 1076,1997[Medline] Yu SW, Wong H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL: Mediation of poly (ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. 

Phrase: "Cell89"

Phrase: ":"

Phrase: "1067 1076,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yu SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Wong H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Poitras MF,"

Phrase: "Coombs C,"

Phrase: "Bowers WJ,"

Phrase: "Federoff HJ,"

Phrase: "Poirier GG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018370:GG [Geographic Area]

Phrase: "Dawson TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Dawson VL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0228339:VL [Body Part, Organ, or Organ Component]
   861   C1424729:VL [Gene or Genome]
   861   C1858854:VL [Disease or Syndrome]

Phrase: ":"

Phrase: "Mediation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680727:Mediation [Social Behavior]

Phrase: "of poly (ADP-ribose) polymerase-1-dependent cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0007587:Cell Death [Cell Function]
   793   C0007634:Cell [Cell]
   793   C0011065:Death [Organism Function]
   793   C1269647:Cell [Cell]
   793   C1306577:Death, NOS [Finding]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
   723   C0032405:poly(ADP-ribose) polymerase-1 [Amino Acid, Peptide, or Protein,Enzyme]
   723   C1538577:POLY(ADP-RIBOSE) POLYMERASE 1 [Gene or Genome]

Phrase: "by apoptosis-inducing factor."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.387: Science297 :259 263,2002[Abstract/Free FullText]

Phrase: "Science297"

Phrase: ":"

Phrase: "259 263,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

